{"study_id": 102780, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review and assess controversial issues related to chronic HBV infection management, including the role of alanine aminotransferase (ALT) in defining treatment criteria.", "results_summary": "The abstract discusses debates on ALT upper limits, nomenclature for HBV infection phases, and antiviral therapy indications but does not provide specific findings on alanine's effects.", "population_specificity": "Patients with chronic HBV infection and HBV-cirrhosis.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:33:57.585460+00:00"}
{"study_id": 102785, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify patient characteristics, including baseline Alanine transaminase (ALT) levels, that modulate the effectiveness of intensive blood pressure control on heart failure risk in individuals with type 2 diabetes.", "results_summary": "The study found that baseline ALT levels influenced the effectiveness of intensive blood pressure control, with only individuals in the lowest ALT tertile (8-19 mg/dl) benefiting from the intervention for heart failure prevention. No significant effects were observed in higher ALT tertiles.", "population_specificity": "Individuals with type 2 diabetes participating in the ACCORD glucose trial and SBP sub-trial.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:33:58.365940+00:00"}
{"study_id": 102781, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the relationship between the Delta variant of COVID-19 and digestive system dysfunction, including the role of alanine aminotransferase (ALT) as a potential marker.", "results_summary": "The study found significant differences in abnormal ALT levels among COVID-19 severity groups, suggesting ALT as a transient marker for severe or critical Delta variant infection. Inactivated vaccines may help prevent severe symptoms and liver dysfunction.", "population_specificity": "Patients infected with the Delta variant of COVID-19, categorized into mild, moderate, and severe or critical illness groups.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:33:58.456412+00:00"}
{"study_id": 102783, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to identify factors associated with elevated serum AFP in HBV-infected patients with non-HCC and early-stage HCC and evaluate AFP's diagnostic performance for early-stage HCC detection.", "results_summary": "Antiviral therapy was negatively associated with elevated AFP, while HBeAg and AST > 1\u00d7 ULN were positively associated with elevated AFP. AFP's diagnostic performance for early-stage HCC was better in patients with antiviral therapy, HBV DNA (\u2212), ALT \u2264 1\u00d7 ULN, and AST \u2264 1\u00d7 ULN.", "population_specificity": "4401 patients with chronic HBV infection (3680 non-HCC, 721 early-stage HCC).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:33:58.665397+00:00"}
{"study_id": 102782, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to validate and replicate dosimetry across multiple sites using alanine pellets as one of the dosimeters to establish a consensus for ultra-high dose rate (UHDR) irradiation studies.", "results_summary": "Alanine provided the closest match between expected and measured dose in UHDR irradiation studies, with excellent agreement (\u00b13%) between replicate experiments, though with certain caveats related to absolute reference dose.", "population_specificity": "Radiation oncology departments (CHUV in Lausanne, Switzerland, and Stanford University, CA) using electron beams for UHDR irradiation.", "effective_dosage": "Expected doses of 7.5 to 16 Gy delivered at UHDR or conventional dose rates.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:33:59.195456+00:00"}
{"study_id": 102784, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of an amino acid-based ORS (VS002A) containing L-alanine against standard glucose-based WHO-ORS in reducing the duration of diarrhea in infants and young children.", "results_summary": "The study suggests that VS002A, which includes L-alanine, may enhance sodium and water absorption in the gut, potentially improving rehydration and bowel barrier function. However, the abstract does not provide specific outcome data, so definitive efficacy conclusions cannot be drawn.", "population_specificity": "Male children aged 6-36 months with acute non-bloody watery diarrhea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:33:59.271756+00:00"}
{"study_id": 102779, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to assess the longer-term efficacy and safety of pembrolizumab versus placebo in patients with clear cell renal cell carcinoma at increased risk of recurrence, not specifically focused on Alanine.", "results_summary": "The study found that pembrolizumab improved disease-free survival compared to placebo, with increased alanine aminotransferase reported as a common adverse event in the pembrolizumab group. No direct effects or outcomes related to Alanine as a supplement were evaluated.", "population_specificity": "Adults aged 18+ with clear cell renal cell carcinoma at increased risk of recurrence post-nephrectomy.", "effective_dosage": "Not applicable (study focused on pembrolizumab, not Alanine).", "study_duration": "Up to 17 cycles (3 weeks per cycle).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:33:59.446982+00:00"}
{"study_id": 102786, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of periodontal treatment (scaling and root planning) in reducing alanine aminotransferase levels and Porphyromonas gingivalis IgG antibody titers in patients with NAFLD and periodontitis.", "results_summary": "The study found that scaling and root planning (SRP) significantly reduced alanine aminotransferase levels and P. gingivalis IgG antibody titers compared to tooth brushing alone, with no reported life-threatening events or treatment-related deaths.", "population_specificity": "Adult patients with NAFLD, periodontitis, alanine aminotransferase levels \u226540 U/L, and steatosis grade \u22651 (18 men and 22 women).", "effective_dosage": "Not specified (intervention was SRP or tooth brushing, not alanine supplementation).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:33:59.506214+00:00"}
{"study_id": 102787, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not focus on Alanine; it evaluates statins for primary prevention of cardiovascular disease.", "results_summary": "The study does not report findings specific to Alanine.", "population_specificity": "Adults at increased CVD risk without prior cardiovascular events.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:05.144598+00:00"}
{"study_id": 102788, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were comparing the safety and efficacy of nedaplatin-based versus cisplatin-based concurrent chemoradiotherapy in cervical cancer patients, including effects on liver function markers like alanine aminotransferase.", "results_summary": "The study found that nedaplatin had a milder gastrointestinal reaction but a more significant effect on liver function (including alanine aminotransferase elevation) compared to cisplatin. No significant differences in overall survival or hematological toxicity were observed between the two groups.", "population_specificity": "Cervical cancer patients (stage IB-IVA), aged 28-82 years.", "effective_dosage": "Weekly intravenous nedaplatin 30 mg/m\u00b2.", "study_duration": "Treatment administered between 10 May 2018 and 31 August 2020 (median follow-up not explicitly stated).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:08.742963+00:00"}
{"study_id": 102791, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether probiotic supplementation influenced plasma alanine levels after Roux-Y gastric bypass (RYGB) surgery.", "results_summary": "The study found that alanine levels decreased in both the probiotic and placebo groups after RYGB, but the reduction was significantly greater in the probiotic group (14.03%, p = 0.03).", "population_specificity": "31 patients who underwent RYGB surgery.", "effective_dosage": "Not specified (probiotic supplement: FloraVantage, containing Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:09.170652+00:00"}
{"study_id": 102790, "supplement_id": 863, "safety_score": "70", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of mitapivat, an oral activator of pyruvate kinase, in reducing transfusion burden among adults with pyruvate kinase deficiency receiving regular transfusions.", "results_summary": "The study found that 37% of participants achieved a \u226533% reduction in transfusion burden. Common adverse events included increased alanine aminotransferase (37%), headache (37%), and increased aspartate aminotransferase (19%), with no treatment-related deaths reported.", "population_specificity": "Adults (\u226518 years) with pyruvate kinase deficiency receiving regular transfusions (at least six episodes in the previous year).", "effective_dosage": "5 mg, 20 mg, and 50 mg twice daily during dose optimization, followed by a fixed dose.", "study_duration": "16-week dose-optimization period and 24-week fixed-dose period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:09.574044+00:00"}
{"study_id": 102794, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to develop a nomogram model using alanine aminotransferase (ALT) and other variables to predict the risk of nonalcoholic fatty liver disease (NAFLD) in Chinese individuals.", "results_summary": "The study identified ALT as one of six significant variables (along with age, sex, waist circumference, BMI, and triglycerides and glucose index) for predicting NAFLD risk. The nomogram model demonstrated high accuracy, with AUROC values of 0.886 (development set) and 0.894 (validation set).", "population_specificity": "8,861 Chinese adults aged 18\u201362 years undergoing physical examinations in Karamay.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:09.871818+00:00"}
{"study_id": 102793, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to analyze the effectiveness of lipid emulsion (LE) treatment for toxicity induced by nonlocal anesthetic drugs in pediatric patients, including drugs like amitriptyline, flecainide, bupropion, propranolol, and lamotrigine.", "results_summary": "The study found that LE improved symptoms of drug toxicity in 93.54% of pediatric patients, with 45.16% showing improvement within an hour of administration. Adverse effects included hypertriglyceridemia, mild pancreatitis, and elevated levels of aspartate and alanine aminotransaminases.", "population_specificity": "Pediatric patients younger than 19 years with toxicity induced by nonlocal anesthetic drugs.", "effective_dosage": "1.5 mL/kg LE bolus followed by 0.25 mL/kg/min continuous infusion.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:09.883350+00:00"}
{"study_id": 102789, "supplement_id": 863, "safety_score": "68", "efficacy_score": 82, "quality_score": 85, "study_goal": "The researchers aimed to assess the safety, tolerability, pharmacokinetics, immunogenicity, and pharmacodynamics of BFKB8488A (a bispecific antibody) in patients with type 2 diabetes mellitus (T2DM) or nonalcoholic fatty liver disease (NAFLD), including its effects on alanine aminotransferase levels.", "results_summary": "BFKB8488A showed trends in exposure-dependent decreases in alanine aminotransferase (ALT) levels (0.7% to 7.3% reduction depending on exposure tertile) compared to placebo (7.5% increase). It also led to significant liver fat reduction in NAFLD patients (13.0% to 49.0% reduction vs. 0.1% with placebo).", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM) or nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Multiple doses at various levels and intervals (weekly, every 2 weeks, or every 4 weeks).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:10.552062+00:00"}
{"study_id": 102795, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of freshwater fish-based and alternating freshwater fish/red meat-based diets on liver steatosis and gut microbiota in NAFLD patients, including the impact on alanine aminotransferase levels.", "results_summary": "The freshwater fish-based diet led to a significantly greater reduction in hepatic steatosis and improved alanine aminotransferase levels compared to the alternating diet, with notable changes in gut microbiota and metabolites.", "population_specificity": "34 NAFLD patients with hepatic steatosis \u226510%.", "effective_dosage": "Not specified (isoenergetic intervention diets).", "study_duration": "84 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:13.764985+00:00"}
{"study_id": 102796, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were evaluating the efficacy and safety of S-1 and irinotecan combination therapy in patients with EGFR-mutated non-small-cell lung cancer previously treated with EGFR tyrosine kinase inhibitors and platinum-based chemotherapy.", "results_summary": "The abstract does not provide specific results regarding Alanine's effects.", "population_specificity": "Patients with EGFR-mutated non-small-cell lung cancer treated with EGFR tyrosine kinase inhibitors and platinum-based chemotherapy.", "effective_dosage": "80 mg/m\u00b2 (frequency not specified).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:17.734619+00:00"}
{"study_id": 102801, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not address Alanine; it focuses on rucaparib maintenance therapy for DRD biomarker-positive metastatic urothelial carcinoma.", "results_summary": "The study does not report any findings related to Alanine.", "population_specificity": "DRD biomarker-positive metastatic urothelial carcinoma patients.", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:18.004330+00:00"}
{"study_id": 102799, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were evaluating the efficacy and safety of bosutinib, not Alanine, in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CP-CML).", "results_summary": "The study found that 60% of patients remained on bosutinib treatment at study completion, with cumulative rates of major molecular response (MMR) reported. Median treatment duration was 35.9 months.", "population_specificity": "Japanese patients with newly diagnosed CP-CML (n=60).", "effective_dosage": "400 mg once daily.", "study_duration": "Median duration of 35.9 months (minimum follow-up of 3 years).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:19.360679+00:00"}
{"study_id": 102797, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the prevalence of Sj\u00f6gren's syndrome (SS) in primary biliary cholangitis (PBC) patients and assess its impact on PBC, including biochemical indicators like alanine transaminase (ALT).", "results_summary": "The study found no significant differences in ALT levels between PBC patients with and without SS. Other biochemical and immunological markers showed varying impacts, but ALT specifically remained unaffected.", "population_specificity": "Adults with primary biliary cholangitis (PBC), some of whom had concomitant Sj\u00f6gren's syndrome (SS).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:19.936868+00:00"}
{"study_id": 102800, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of obeticholic acid (OCA) and fibric acid derivatives as second-line treatments for primary biliary cholangitis, focusing on biochemical response rates and drug discontinuation.", "results_summary": "At 12 months, fibric acid derivatives showed a greater reduction in alkaline phosphatase (56.7%) compared to OCA (29.5%), but OCA had higher rates of normalizing serum alanine transaminase and bilirubin (55.9% and 36.4%, respectively). Overall biochemical response rates were similar between the two treatments (70.6% for OCA vs. 80% for fibric acids).", "population_specificity": "Patients with primary biliary cholangitis in the United Kingdom who inadequately responded to ursodeoxycholic acid.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:20.139037+00:00"}
{"study_id": 102798, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of perioperative supplementation with a combination of L-glutamine, L-arginine, and \u03b2-hydroxy-\u03b2-methylbutyrate (HMB) on recovery, myocardial injury, and hospital stay in cardiac surgery patients.", "results_summary": "The study found that supplementation with Gln/Arg/HMB reduced serum levels of CPK-MB, troponin, bilirubin, and SOFA scores, as well as decreased hospital and ICU stay durations compared to placebo.", "population_specificity": "70 patients undergoing cardiac surgery (60 completed the study, mean age 53.13 \u00b1 14.35 years).", "effective_dosage": "2 sachets daily (7 g L-arginine, 7 g L-glutamine, and 1.5 g HMB per day).", "study_duration": "30 days before surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:20.267679+00:00"}
{"study_id": 102792, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the progression of liver disease in children with cystic fibrosis (CF) who had nodular liver (NOD) detected via ultrasound versus those with normal liver (NL) findings.", "results_summary": "The study found that children with NOD developed clinically evident portal hypertension faster than those with NL, but growth and lung disease progression were similar between the two groups. Platelet counts were lower in the NOD group at baseline, suggesting potential liver dysfunction.", "population_specificity": "Children with cystic fibrosis (CF) and nodular liver (NOD) or normal liver (NL) findings.", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:20.301844+00:00"}
{"study_id": 102802, "supplement_id": 863, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of Biejia-Ruangan tablet (CBRT) as an adjunctive therapy to entecavir for treating hepatic fibrosis in chronic hepatitis B patients.", "results_summary": "The study found that CBRT combined with entecavir significantly improved serum biochemical markers (hyaluronic acid, laminin, PC-III, IV-C) and liver function indices (ALT, AST, TBiL) compared to entecavir alone, with a lower adverse event rate.", "population_specificity": "Chronic hepatitis B (HBV) patients complicated with hepatic fibrosis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:22.662394+00:00"}
{"study_id": 102804, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of continuous intake of salmon milt DNA on improving liver function, as indicated by alanine aminotransferase (ALT) levels, in healthy participants.", "results_summary": "The study found that salmon milt DNA intake over 12 weeks improved liver function in participants with elevated ALT levels, though specific statistical outcomes are not detailed in the abstract.", "population_specificity": "50 healthy Japanese participants aged 30 to 70 years with ALT levels of 25-87 U/L.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:25.847972+00:00"}
{"study_id": 102806, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to synthesize data on the effects of Mediterranean Diet and Calorie Restriction interventions on NAFLD surrogate markers, including alanine aminotransferase (ALT), in adults.", "results_summary": "Dietary interventions, including calorie restriction and Mediterranean diet, significantly reduced ALT levels (P < 0.001 and P = 0.02, respectively), indicating improved liver function in NAFLD patients.", "population_specificity": "Adults with non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:27.358159+00:00"}
{"study_id": 102807, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to identify predictors of mortality, including serum alanine aminotransferase levels, among critically ill COVID-19 patients in Nepal.", "results_summary": "The study found that elevated serum alanine aminotransferase was one of the biochemical predictors of mortality in COVID-19 patients admitted to critical care units.", "population_specificity": "Critically ill COVID-19 patients admitted to critical care units across seven provinces in Nepal.", "effective_dosage": "Not available", "study_duration": "Data was collected over a three-month period (April 14, 2021 to July 15, 2021).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:27.532775+00:00"}
{"study_id": 102808, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 30, "study_goal": "The study aimed to report a case of EBV-associated cholangiocarcinoma and highlight the role of EBV infection in liver cancer diagnosis.", "results_summary": "The study reported elevated alanine aminotransferase levels (242 U/L) in a patient with EBV-associated cholangiocarcinoma, but did not investigate alanine's therapeutic or supplemental effects. The patient's condition deteriorated post-treatment, leading to death.", "population_specificity": "A 36-year-old female with EBV-associated cholangiocarcinoma.", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:27.895913+00:00"}
{"study_id": 102810, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not investigate Alanine; it examines the effect of mild moxibustion on cancer-related fatigue in NSCLC patients undergoing chemotherapy.", "results_summary": "The study found that mild moxibustion alleviated cancer-related fatigue in NSCLC patients but did not improve their quality of life. No adverse events or liver/kidney toxicity were reported.", "population_specificity": "Non-small-cell lung cancer (NSCLC) patients undergoing initial chemotherapy.", "effective_dosage": "Not applicable (study did not involve Alanine).", "study_duration": "Moxibustion was administered during chemotherapy for 30 minutes per day.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:30.456700+00:00"}
{"study_id": 102812, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The study aimed to compare clinical characteristics and laboratory findings of COVID-19 patients with and without complications, including the role of alanine aminotransferase as a prognostic biomarker.", "results_summary": "The study found that elevated alanine aminotransferase levels, along with other biomarkers like CRP, d-dimer, and LDH, were significantly linked to the severity of COVID-19. However, the abstract does not specify direct effects or outcomes related to alanine supplementation or intervention.", "population_specificity": "75 confirmed COVID-19 positive patients, including 49 severely-ill cases.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:31.095752+00:00"}
{"study_id": 102809, "supplement_id": 863, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and preliminary efficacy of cilofexor, a nonsteroidal farnesoid X receptor agonist, in treating primary sclerosing cholangitis (PSC) over a 96-week open-label extension study.", "results_summary": "Cilofexor improved liver biochemistry and biomarkers of cholestasis and cellular injury, with significant reductions in GGT, ALT, AST, and C4 levels, though ALP reductions were modest and not statistically significant. Safety was generally acceptable, with pruritus and other adverse events leading to discontinuation in 32% of subjects.", "population_specificity": "Noncirrhotic subjects with large-duct PSC (median age 44 years, 60% male, 60% with inflammatory bowel disease, 45% on ursodeoxycholic acid).", "effective_dosage": "100 mg daily.", "study_duration": "96 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:32.270266+00:00"}
{"study_id": 102813, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of D-alanine and other D-amino acids as an augmentation strategy for treatment-resistant schizophrenia (TRS) by modulating NMDAR function.", "results_summary": "The study suggests that D-alanine, along with other D-amino acids, may improve outcomes in TRS by targeting glutamatergic abnormalities, though specific efficacy data for D-alanine alone are not detailed. The impact on synaptic architecture and dendritic spine changes was also considered.", "population_specificity": "Patients with treatment-resistant schizophrenia (TRS), affecting 30-40% of schizophrenia cases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:32.884063+00:00"}
{"study_id": 102816, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effectiveness of silymarin nanomicelles on symptom resolution, laboratory parameters, and liver enzymes (including alanine aminotransferase) in COVID-19 patients.", "results_summary": "The study found no significant differences between silymarin and placebo groups in symptom resolution time, laboratory parameters, or hospitalization duration. However, alanine aminotransferase levels decreased significantly in the treatment group compared to placebo.", "population_specificity": "Patients with COVID-19 (n=50, split into treatment and placebo groups).", "effective_dosage": "70 mg silymarin as nanomicelles, three times daily.", "study_duration": "Two weeks.", "interactions": "Concomitant use of dexamethasone and remdesivir might obscure silymarin's effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:38.347597+00:00"}
{"study_id": 102817, "supplement_id": 863, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the clinical and biological safety of pyronaridine-artesunate (PA), with a focus on hepatotoxicity markers like alanine aminotransferase (ALT) and aspartate aminotransferase (AST), in real-life conditions for malaria treatment.", "results_summary": "The study found that PA was well-tolerated, with 97.8% of patients reporting no adverse events. No clinical or biological hepatotoxicity related to PA was observed, and biochemistry parameters remained within normal ranges.", "population_specificity": "Patients with uncomplicated malaria attending health facilities in Nanoro, Burkina Faso.", "effective_dosage": "PA administered orally once a day for 3 days.", "study_duration": "28-day follow-up after treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:38.464948+00:00"}
{"study_id": 102815, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore associations between alanine aminotransferase (ALT) levels and other biochemical parameters in lean women with polycystic ovary syndrome (PCOS) to identify potential risk factors for liver impairment.", "results_summary": "Higher ALT levels were found in lean PCOS patients, with positive correlations to BMI, total testosterone, white blood cell count, lymphocyte count, aspartate aminotransferase, and uric acid. Total testosterone and aspartate aminotransferase were independently associated with ALT levels, suggesting a potential risk of early liver impairment in this population.", "population_specificity": "Lean women with PCOS (n=91) and healthy controls (n=45).", "effective_dosage": "Not available", "study_duration": "Retrospective data from January 2019 to September 2021 (no specific intervention duration).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:38.962803+00:00"}
{"study_id": 102818, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the clinical effects of wheat germ, including its impact on alanine aminotransferase (ALT) levels, in patients with NAFLD.", "results_summary": "Wheat germ consumption significantly reduced serum alanine aminotransferase (ALT), \u03b3-glutamyltransferase (GGT), total cholesterol, triglycerides, and hepatic steatosis levels, while increasing total antioxidant capacity (TAC) and reducing hs-CRP levels compared to placebo.", "population_specificity": "Fifty participants with NAFLD.", "effective_dosage": "40 g wheat germ daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:39.129732+00:00"}
{"study_id": 102820, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the evidence base on liver function test (LFT) assessment in infectious mononucleosis (IM), including the role of alanine transaminase (ALT) abnormalities, time to resolution, and the necessity of abdominal ultrasound.", "results_summary": "The study found that 62% of patients with IM had abnormal alanine transaminase (ALT) levels, with a median time to resolution of 8 weeks. Routine LFT assessments and abdominal ultrasound were deemed unnecessary for immunocompetent patients with subclinical derangement.", "population_specificity": "Adult and pediatric patients with infectious mononucleosis (IM).", "effective_dosage": "Not available", "study_duration": "Not applicable (observational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:41.012473+00:00"}
{"study_id": 102819, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to evaluate the safety and antitumour activity of zandelisib, a PI3K\u03b4 inhibitor, with continuous or intermittent dosing in patients with relapsed or refractory B-cell malignancy.", "results_summary": "The study found that zandelisib was safe with intermittent dosing, showing low frequency of grade 3 or worse adverse events, and demonstrated antitumour activity across evaluated doses. Alanine aminotransferase increase was noted as a grade 3-4 adverse event in some patients.", "population_specificity": "Patients aged 18 or older with relapsed or refractory B-cell malignancy (follicular lymphoma or chronic lymphocytic leukaemia).", "effective_dosage": "60 mg, 120 mg, or 180 mg once daily (oral zandelisib).", "study_duration": "Median duration of exposure was 15.2 months (IQR 3.7-21.7).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:41.942909+00:00"}
{"study_id": 102821, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of Mycobacterium w (Mw) along with standard of care (SOC) in critically ill COVID-19 patients, including its impact on laboratory parameters and clinical outcomes.", "results_summary": "The study found that Mw plus SOC was associated with higher mortality and longer hospital stays compared to SOC alone, but early initiation of Mw (<3 days) showed reduced mortality, ICU stay, and improved lab markers like CRP and D-dimer.", "population_specificity": "Critically ill COVID-19 patients admitted to five tertiary care centers in India.", "effective_dosage": "0.3 mL intradermal Mw for 3 consecutive days.", "study_duration": "3 days of Mw administration during hospitalization.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:42.422210+00:00"}
{"study_id": 102824, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify non-invasive biomarkers, including alanine aminotransferase (ALT), for diagnosing NASH and liver fibrosis.", "results_summary": "The study found that ALT, combined with other biomarkers, significantly improved diagnostic accuracy for NASH and liver fibrosis, with high sensitivity and specificity in both discovery and validation cohorts.", "population_specificity": "250 patients with histologically proven NAFL or NASH, with or without fibrosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:46.150331+00:00"}
{"study_id": 102822, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers were evaluating the clinical efficacy and safety of simvastatin in patients with liver cirrhosis, not specifically Alanine.", "results_summary": "The study found that simvastatin significantly reduced mortality rates and fatal bleeding in cirrhotic patients, while not significantly affecting alanine aminotransferase (ALT) levels or causing other side effects.", "population_specificity": "Patients with liver cirrhosis", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:46.252686+00:00"}
{"study_id": 102814, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The study aimed to investigate the effects of Clostridium butyricum capsules combined with rosuvastatin on intestinal flora, lipid metabolism, liver function, and inflammation in NAFLD patients, with alanine aminotransferase (ALT) as one of the measured liver function markers.", "results_summary": "The combination treatment significantly improved intestinal flora balance, reduced blood lipid levels, and alleviated liver fibrosis and liver function damage, including lower ALT levels, compared to rosuvastatin alone.", "population_specificity": "96 patients with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified for Alanine (ALT was a biomarker, not an intervention).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:46.665349+00:00"}
{"study_id": 102825, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to characterize metabolic pathways, including the glucose-alanine cycle, in dogs with sepsis to identify potential diagnostic and prognostic biomarkers.", "results_summary": "The study identified alterations in the glucose-alanine cycle among other metabolic pathways in dogs with sepsis, suggesting its potential role as a biomarker. Alanine-related pathways were enriched, but direct efficacy outcomes were not explicitly detailed.", "population_specificity": "21 client-owned dogs with sepsis and 20 healthy control dogs.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:46.867234+00:00"}
{"study_id": 102823, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of fenofibrate on liver biochemistries, including alanine aminotransferase (ALT), in patients with primary sclerosing cholangitis (PSC).", "results_summary": "The study found that fenofibrate significantly reduced ALT levels by 52.78% in PSC patients, along with a notable decrease in alkaline phosphatase (ALP). However, other secondary endpoints, such as improvements in the Mayo Risk Score and bilirubin levels, were not met.", "population_specificity": "Patients with primary sclerosing cholangitis (PSC), 19 female and 11 male, aged 40.2 \u00b1 9.2 years, all previously treated with Ursodeoxycholic acid.", "effective_dosage": "200 mg of fenofibrate once per day.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:49.049016+00:00"}
{"study_id": 102827, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the relationship between liver function tests (including alanine aminotransferase, ALT) and major cardiorenal outcomes in type 2 diabetes patients, and the impact of canagliflozin treatment.", "results_summary": "ALT was independently associated with lower cardiovascular outcomes risk, while \u03b3GT and ALP were linked to higher risks. Canagliflozin treatment reduced ALT, AST, and \u03b3GT levels over time and lowered heart failure and renal risk independently of liver function tests.", "population_specificity": "10,142 patients with type 2 diabetes and high cardiovascular risk.", "effective_dosage": "Not specified", "study_duration": "Repeated measurements over follow-up (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:50.032320+00:00"}
{"study_id": 102829, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effects of endoscopic bariatric and metabolic therapies (EBMTs) on non-alcoholic fatty liver disease (NAFLD) in patients with obesity, including the impact on liver parameters such as alanine transaminase.", "results_summary": "EBMTs significantly reduced serum levels of alanine transaminase, improved liver steatosis, and ameliorated NAFLD-related outcomes, including liver function and insulin resistance. The study also noted weight loss and metabolic improvements.", "population_specificity": "Patients with obesity and NAFLD.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:50.088942+00:00"}
{"study_id": 102826, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to assess the efficacy and safety of cabozantinib plus atezolizumab versus sorafenib as first-line systemic treatment for advanced hepatocellular carcinoma, not specifically focused on Alanine.", "results_summary": "The study found that cabozantinib plus atezolizumab improved progression-free survival compared to sorafenib but did not show a significant difference in overall survival. Adverse events, including alanine aminotransferase increase, were more common in the combination treatment group.", "population_specificity": "Patients aged 18 years or older with advanced hepatocellular carcinoma, not previously treated with systemic anticancer therapy.", "effective_dosage": "Not applicable (study focused on cabozantinib and atezolizumab, not Alanine).", "study_duration": "Median follow-up was 15.8 months for progression-free survival and 13.3 months for overall survival.", "interactions": "None mentioned (related to Alanine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:50.967027+00:00"}
{"study_id": 102833, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compile the roles of viral and human enzymes, including proteases, in the context of SARS-CoV-2 infection.", "results_summary": "The abstract highlights that proteases are vital for SARS-CoV-2 infection, focusing on the main protease (Mpro), but does not specifically address Alanine's effects.", "population_specificity": "Not specified (general context of SARS-CoV-2 infection)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:53.682920+00:00"}
{"study_id": 102832, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the hepatoprotective effects of Artichoke leaf extract (ALE) on alanine aminotransferase levels in patients with nonalcoholic fatty liver disease (NAFLD).", "results_summary": "The meta-analysis of five RCTs showed that ALE significantly reduced alanine aminotransferase levels (SMD: 1.1; 95% CI, 0.79-1.73), indicating a beneficial effect on liver health in NAFLD patients.", "population_specificity": "Patients with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:54.651570+00:00"}
{"study_id": 102830, "supplement_id": 863, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of saroglitazar, including its effects on alanine aminotransferase, in patients with dyslipidemia.", "results_summary": "Saroglitazar significantly reduced LDL and total cholesterol without adverse effects on serum creatinine, alanine aminotransferase, aspartate aminotransferase, or bodyweight. The drug appeared effective and safe for dyslipidemia management.", "population_specificity": "581 adults with dyslipidemia, mean age 40.2\u201362.6 years.", "effective_dosage": "2 mg and 4 mg saroglitazar.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:54.656844+00:00"}
{"study_id": 102831, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the relationship between tepotinib exposure and its efficacy and safety outcomes in NSCLC patients with METex14 skipping alterations.", "results_summary": "Tepotinib showed flat exposure-efficacy and exposure-safety relationships within the tested dose ranges, with edema being the most frequent adverse event. Concentration-QTc analyses indicated minimal QT interval prolongation at therapeutic and supratherapeutic doses.", "population_specificity": "Non-small cell lung cancer (NSCLC) patients harboring METex14 skipping alterations.", "effective_dosage": "500 mg/day (therapeutic dose), with additional doses tested ranging from 30-1400 mg.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:55.196273+00:00"}
{"study_id": 102834, "supplement_id": 863, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to explore the efficacy and renal safety of tenofovir alafenamide (TAF) treatment in chronic hepatitis B patients after one year.", "results_summary": "Virological suppression was achieved in 83% of patients, with a median decline in HBV DNA of 5.18 log IU/mL. ALT normalization occurred in 75.7%, and HBsAg levels decreased significantly, though modest changes in renal function (eGFR and creatinine) were observed.", "population_specificity": "148 chronic hepatitis B patients (42 HBeAg-positive and 106 HBeAg-negative).", "effective_dosage": "Not specified", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:57.096502+00:00"}
{"study_id": 102835, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the clinical efficacy of laparoscopic surgery versus conventional laparotomy in treating acute cholangitis of severe type (ACST).", "results_summary": "The meta-analysis found that laparoscopic surgery was associated with improved treatment efficiency, reduced complication risk, and better outcomes in ACST patients compared to conventional laparotomy.", "population_specificity": "Patients with acute cholangitis of severe type (ACST).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:57.149691+00:00"}
{"study_id": 102836, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of a calorie-restricted diet on oxidative/anti-oxidative status in NAFLD patients, including the role of serum alanine aminotransferase (ALT).", "results_summary": "The study found significant reductions in serum ALT levels in the calorie-restricted diet group compared to controls, but no significant changes in oxidative/anti-oxidative markers.", "population_specificity": "60 patients with NAFLD, aged 20-60 years, BMI 25-35 kg/m\u00b2.", "effective_dosage": "Not specified (calorie-restricted diet only).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:34:57.987479+00:00"}
{"study_id": 102837, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of entecavir (ETV) versus ETV maleate in Chinese patients with chronic hepatitis B (CHB), focusing on HBV DNA reduction and other viral markers.", "results_summary": "The study found similar declines in HBV DNA levels between the two treatment groups for HBeAg-positive CHB patients, with no significant differences in secondary endpoints like HBV DNA detection below LLOD, HBeAg loss, or ALT normalization. Adverse events were recorded but not detailed in the abstract.", "population_specificity": "Chinese patients with chronic hepatitis B (HBeAg-positive and HBeAg-negative).", "effective_dosage": "0.5 mg/day of ETV or ETV maleate.", "study_duration": "240 weeks (48 weeks initial treatment, followed by extended treatment and follow-up).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:00.397746+00:00"}
{"study_id": 102838, "supplement_id": 863, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the safety and efficacy of pyronaridine-artesunate, including its impact on liver enzymes like alanine aminotransferase (ALT), compared to other antimalarial treatments for uncomplicated P. falciparum malaria.", "results_summary": "Pyronaridine-artesunate was associated with elevated ALT levels but showed high efficacy with PCR-adjusted treatment failure rates below 5%. Liver enzyme increases were generally mild and reversible by day 42.", "population_specificity": "Individuals with uncomplicated P. falciparum malaria, including 541 children under five, across 13 African and five Asian sites.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Follow-up periods included days 28 and 42 post-treatment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:02.034515+00:00"}
{"study_id": 102839, "supplement_id": 863, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether licogliflozin (a sodium-glucose cotransporter inhibitor) could improve serum alanine aminotransferase levels in patients with NASH.", "results_summary": "Licogliflozin 150 mg significantly reduced serum alanine aminotransferase by 32% compared to placebo, while the 30 mg dose did not meet statistical significance. Diarrhea was a common side effect but was mostly mild in severity.", "population_specificity": "107 patients with phenotypic or histologic NASH.", "effective_dosage": "30 mg or 150 mg once daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:02.260950+00:00"}
{"study_id": 102840, "supplement_id": 863, "safety_score": "75", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to assess the safety and efficacy of GSK3389404, an antisense oligonucleotide targeting HBV RNA, in reducing viral proteins in patients with chronic HBV infection.", "results_summary": "GSK3389404 showed dose-dependent reductions in HBsAg levels with an acceptable safety profile, but no clear optimal dosing regimen was identified. The study found modest efficacy, with only a few patients achieving significant HBsAg responses.", "population_specificity": "Patients with chronic hepatitis B on nucleos(t)ide analogue therapy.", "effective_dosage": "30, 60, 120 mg weekly or 120 mg bi-weekly.", "study_duration": "Until Day 85.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:02.653844+00:00"}
{"study_id": 102841, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the association between clinical laboratory parameters (including alanine aminotransferase) and fatality in patients with severe fever with thrombocytopenia syndrome (SFTS).", "results_summary": "Alanine aminotransferase (ALT) was identified as one of the factors contributing to the risk of dying in SFTS patients, though its standardized mean difference (SMD) was not as strongly associated with mortality as other parameters like viral load or platelet count.", "population_specificity": "SFTS patients across three countries (over 3300 participants).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:04.237241+00:00"}
{"study_id": 102842, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of a fruit-rich diet (FRD) on liver steatosis, liver enzymes (including alanine aminotransferase (ALT)), insulin resistance, and lipid profile in patients with NAFLD.", "results_summary": "The study found that consuming more than 4 servings of fruits per day exacerbated steatosis, dyslipidemia, and glycemic control in NAFLD patients, with no significant improvement in liver enzymes like ALT.", "population_specificity": "Eighty adults with Non-Alcoholic Fatty Liver Disease (NAFLD).", "effective_dosage": "At least 4 servings of fruits daily (FRD group) vs. less than 2 servings/day (control group).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:05.040401+00:00"}
{"study_id": 102843, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of semaglutide in improving alanine aminotransferase (ALT) levels and other measures in patients with metabolic-dysfunction associated fatty liver disease (MAFLD) and/or type-2 diabetes (T2DM).", "results_summary": "Injectable semaglutide (0.4mg/0.5mg once weekly) significantly lowered ALT levels and improved certain radiologic features in MAFLD, though conclusions were limited by the small number of patients evaluated.", "population_specificity": "Patients with MAFLD and/or type-2 diabetes (2115 participants across 4 RCTs).", "effective_dosage": "0.4mg/0.5mg once weekly (injectable).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:05.927673+00:00"}
{"study_id": 102844, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers investigated the spectrum of bile duct injury and associated natural history in patients with immune-related hepatitis (irH) during treatment with immune checkpoint inhibitors (CPI), including the role of alanine aminotransferase levels.", "results_summary": "The study identified CPI-related cholangiopathy with elevated alanine aminotransferase levels, poor response to immunosuppression, and potential progression to bile duct loss. Clinical jaundice and radiological evidence of bile duct pathology were common, with a high mortality rate primarily due to malignancy progression.", "population_specificity": "Patients with bile duct injury during CPI treatment for malignancy in three tertiary hospitals (n=10).", "effective_dosage": "Not specified", "study_duration": "Median CPI cycles prior to bile duct injury was 6 (specific duration not detailed).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:07.469811+00:00"}
{"study_id": 102845, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a combination of amino acids including alanine (SAGAT) could improve mental health outcomes such as fatigue sensation, motivation, and cognitive function.", "results_summary": "The study found no significant differences in primary outcomes (fatigue sensation), but the SAGAT group showed significant improvements in motivation and cognitive function during recovery after mental work compared to the placebo.", "population_specificity": "Adults aged 20-65 years with fatigue sensation.", "effective_dosage": "Not specified", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:08.807420+00:00"}
{"study_id": 102848, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine the effects of grape products on liver enzymes, including alanine aminotransferase (ALT), in adults.", "results_summary": "The meta-analysis found no significant change in serum ALT levels after grape product consumption, indicating no meaningful effect on liver enzymes. The results were inconclusive due to the limited number of included studies.", "population_specificity": "Adults (291 participants across 8 RCTs)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:09.383539+00:00"}
{"study_id": 102847, "supplement_id": 863, "safety_score": "20", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize the role of environmental bacteria, including the cyanobacterial toxin BMAA (\u03b2-N-methylamino-L-alanine), in brain diseases, focusing on toxicological mechanisms.", "results_summary": "The study found that BMAA and its isomers act through multiple toxicological pathways, including inflammation, oxidative stress, and excitotoxicity, but further research is needed to clarify cocktail effects and intervention targets.", "population_specificity": "Not specified (in vitro and in vivo models referenced).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:09.956530+00:00"}
{"study_id": 102849, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify risk factors, including elevated alanine aminotransferase (ALT) levels, associated with liver-related morbidity and death after HCV cure.", "results_summary": "Elevated ALT and GGT levels post-HCV cure were predictive of adverse liver outcomes, with GGT being the strongest predictor, particularly in combination with cirrhosis. Elevated ALT (AASLD criteria) and standard ALT also predicted hepatic decompensation.", "population_specificity": "6982 patients from the German Hepatitis C Registry with follow-up for up to 7 years post-DAA therapy.", "effective_dosage": "Not specified", "study_duration": "Up to 7 years of follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:12.063350+00:00"}
{"study_id": 102850, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of curcumin on liver ultrasonographic morphology and its effectiveness as an adjuvant treatment for NAFLD.", "results_summary": "Curcumin improved NAFLD severity and liver steatosis resolution, reduced liver enzymes (AST, ALT), total cholesterol, and BMI in participants with NAFLD.", "population_specificity": "Participants with NAFLD (1028 individuals across 16 RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:12.714231+00:00"}
{"study_id": 102852, "supplement_id": 863, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of compound glycyrrhizin (CG) in improving liver function and treating liver cancer, focusing on its impact on alanine aminotransferase (ALT) and other liver markers.", "results_summary": "CG treatment significantly improved ALT, AST, TBIL, and ALB levels in liver cancer patients, showing higher efficacy than the control group. Adverse reactions, though slightly higher, were manageable.", "population_specificity": "Patients with primary and metastatic liver cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:14.857960+00:00"}
{"study_id": 102851, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study aimed to compare the long-term effectiveness and safety of SGLT2 inhibitors (dapagliflozin and empagliflozin) as add-on therapy in type 2 diabetes patients, not specifically Alanine.", "results_summary": "The study found that both dapagliflozin and empagliflozin significantly improved clinical parameters like HbA1c, fasting plasma glucose, and body weight over 36 months, with no significant difference in efficacy between doses. Adverse drug reactions were reported in 7-8% of patients, primarily urinary tract infections.", "population_specificity": "Patients with type 2 diabetes (680 initially, 468 after propensity score matching).", "effective_dosage": "Not specified for Alanine.", "study_duration": "36 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:15.318347+00:00"}
{"study_id": 102855, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effect of berberis aristate and Silybum marianum on alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in adults.", "results_summary": "The study found no statistically significant change in ALT or AST levels following BBR-silymarin consumption. The results suggest no significant reduction in liver enzymes from the supplement.", "population_specificity": "Adults (549 participants across 5 trials)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:17.446901+00:00"}
{"study_id": 102853, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of an alanine aminotransferase-based algorithm in determining eligibility for tenofovir disoproxil fumarate to prevent mother-to-child transmission of HBV.", "results_summary": "The study found that an immunoglobulin-free strategy using an HBeAg rapid test and alanine aminotransferase-based algorithm was effective in preventing HBV transmission when tenofovir was initiated at least 4 weeks before birth, with a 1% HBV infection rate in infants.", "population_specificity": "Pregnant women positive for HBsAg, aged 18 or older, excluding those with HCV, HIV, severe gravid disease, or low creatinine clearance.", "effective_dosage": "300 mg of tenofovir disoproxil fumarate orally once daily.", "study_duration": "From the 24th week of gestation until 6 weeks postpartum.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:17.846107+00:00"}
{"study_id": 102856, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to investigate the protective effect of nano-curcumin (NC) on inflammatory biomarkers, endothelial function, oxidative stress indices, biochemical factors, nutritional status, and clinical outcomes in patients with sepsis.", "results_summary": "The abstract does not mention Alanine or its effects, focusing instead on nano-curcumin.", "population_specificity": "ICU-admitted patients with sepsis.", "effective_dosage": "Not mentioned for Alanine.", "study_duration": "10 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:18.999366+00:00"}
{"study_id": 102854, "supplement_id": 863, "safety_score": "80", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the safety and clinical activity of olutasidenib (not Alanine) in patients with relapsed/refractory gliomas harboring an IDH1R132X mutation.", "results_summary": "Olutasidenib was well tolerated with no dose-limiting toxicities observed; disease control rate was 48%, with 8% achieving partial response and 32% stable disease for at least 4 months. Grade 3-4 adverse events included increased alanine aminotransferase and aspartate aminotransferase in 12% of patients.", "population_specificity": "Patients \u226518 years with relapsed/refractory IDH1R132X-mutated glioma.", "effective_dosage": "150 mg orally twice daily.", "study_duration": "Continuous 28-day cycles (median follow-up 15.1 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:20.397096+00:00"}
{"study_id": 102857, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to examine factors predisposing hospitalized COVID-19 patients to falls, including the role of alanine aminotransferase (ALT) levels.", "results_summary": "The study found that ALT levels were significantly lower in COVID-19 patients who fell compared to those who did not (17.1 vs 33.5 IU/L, P=0.041). No direct conclusions about alanine's efficacy or safety were drawn.", "population_specificity": "Hospitalized COVID-19 patients (median age 75 years, 51.3% male).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:21.303865+00:00"}
{"study_id": 102846, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of a customized hypocaloric diet and enhanced physical activity on intrahepatic fat content and NAFLD progression in patients with metabolic syndrome, including evaluating biochemical parameters such as alanine aminotransferase (ALT).", "results_summary": "The study found that participants with NAFLD and MetS showed reduced intrahepatic fat content and liver stiffness, along with improvements in BMI, insulin, HbA1c, diastolic blood pressure, HDL-cholesterol, and ALT levels. Dietary and physical activity interventions also led to better energy, fish, and legume consumption.", "population_specificity": "155 participants (40-60 years old) from Spain with NAFLD, MetS, and a BMI between 27 and 40 kg/m\u00b2.", "effective_dosage": "Not specified", "study_duration": "6 and 12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:22.133019+00:00"}
{"study_id": 102858, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the efficacy and safety of radiation segmentectomy as a treatment for unresectable very early to early stage hepatocellular carcinoma with suboptimal location for ablation, not specifically related to Alanine.", "results_summary": "The study found that radiation segmentectomy was efficacious, with 83% of patients showing complete response and 90% sustaining complete response. Adverse events were mostly mild to moderate, with few high-grade events.", "population_specificity": "Adults (>18 years) with solitary hepatocellular carcinoma (\u22643 cm), Child-Pugh score A-B7, ECOG score 0, and adequate organ function.", "effective_dosage": "Not mentioned", "study_duration": "Follow-up for up to 24 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:23.688955+00:00"}
{"study_id": 102859, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy of ursodeoxycholic acid (UDCA) in reducing liver damage markers, including alanine aminotransferase (ALT), in patients with nonalcoholic steatohepatitis (NASH).", "results_summary": "UDCA treatment significantly reduced blood concentrations of ALT and \u03b3-glutamyl transferase (GGT) but had no significant effect on anthropometric characteristics or hepatic histology.", "population_specificity": "Patients with nonalcoholic steatohepatitis (NASH)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:23.779008+00:00"}
{"study_id": 102861, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not focus on Alanine; it evaluates the clinical efficacy and tolerability of onasemnogene abeparvovec in SMA type 1 patients.", "results_summary": "The study does not report findings related to Alanine.", "population_specificity": "SMA type 1 patients aged 1.7-48 months.", "effective_dosage": "Not mentioned for Alanine.", "study_duration": "Not applicable for Alanine.", "interactions": "None mentioned for Alanine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:25.007370+00:00"}
{"study_id": 102860, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop and validate a novel risk stratification model (ABC model) for hepatic decompensation in compensated advanced chronic liver disease (cACLD) patients, incorporating alanine aminotransferase (ALT) as one of the independent risk factors.", "results_summary": "The study found that ALT, along with other factors like liver stiffness measurement (LSM), platelet count, albumin, and varices, was an independent predictor of hepatic decompensation risk in cACLD patients. The ABC model, which included ALT, demonstrated strong predictive accuracy for decompensation risk (3-year tAUC of 0.851 in the training cohort and 0.843 in the validation cohort).", "population_specificity": "Patients with compensated advanced chronic liver disease (cACLD).", "effective_dosage": "Not specified.", "study_duration": "Data collected from January 2009 to August 2021 (follow-up duration not explicitly stated).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:27.273151+00:00"}
{"study_id": 102862, "supplement_id": 863, "safety_score": "30", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the risk of drug-induced liver injury (DILI) associated with antirheumatic drugs, including the role of alanine aminotransferase (ALT) elevation as a potential indicator.", "results_summary": "The study highlights that ALT elevation in clinical trials may predict severe liver injury, with biologic and targeted synthetic DMARDs posing lower risks but still capable of causing liver damage. Pre-existing conditions like NAFLD, diabetes, and obesity may exacerbate DILI.", "population_specificity": "Patients with rheumatoid arthritis or other conditions treated with antirheumatic drugs.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:27.955384+00:00"}
{"study_id": 102863, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not address Alanine; it focuses on the safety and efficacy of a liver-tropic adeno-associated virus vector (BBM-H901) for haemophilia B gene therapy.", "results_summary": "The study found that BBM-H901 increased FIX concentrations and reduced bleeding frequency in haemophilia B patients, with no serious adverse events reported.", "population_specificity": "Adult male patients with haemophilia B (baseline FIX:C <2 IU/dL, no FIX inhibitor, low titre of neutralising antibodies).", "effective_dosage": "Single intravenous infusion of 5 \u00d7 10^12 vg/kg.", "study_duration": "Median follow-up of 58 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:28.555405+00:00"}
{"study_id": 102864, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of diammonium glycyrrhizinate (DG) in improving liver function and treating chronic hepatitis B (CHB) compared to conventional treatments.", "results_summary": "DG effectively reduced liver-function markers (ALT, AST, TBIL) and improved liver-function recovery, showing superior effects to conventional treatment within the first 3 months. Different DG dosage forms varied in efficacy, with capsules performing comparably to other drugs, while enteric-coated capsules and injections were less effective.", "population_specificity": "Patients with chronic hepatitis B (CHB).", "effective_dosage": "Not specified.", "study_duration": "Up to 3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:30.349563+00:00"}
{"study_id": 102867, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate drug-induced liver injury (DILI) in COVID-19 patients using the RUCAM method, focusing on clinical features and causality assessment.", "results_summary": "The study identified DILI cases in COVID-19 patients, primarily caused by antiviral drugs, with hepatocellular injury being more common than cholestatic or mixed injury. Outcomes were mostly favorable, though fatal in 19 cases.", "population_specificity": "COVID-19 patients with suspected drug-induced liver injury (DILI).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:31.131333+00:00"}
{"study_id": 102866, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the clinical significance of alanine and other PFAAs in predicting overall survival in NSCLC patients treated with PD-1 inhibitors.", "results_summary": "Higher plasma concentrations of alanine were significantly correlated with better overall survival in NSCLC patients receiving PD-1 inhibitors, suggesting its potential role as a biomarker for treatment response.", "population_specificity": "53 patients with non-small cell lung cancer (NSCLC) before treatment with PD-1 inhibitors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:32.093274+00:00"}
{"study_id": 102865, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of combination therapy with tofogliflozin and pioglitazone on hepatic steatosis and diabetes mellitus in patients with NAFLD and T2DM, including its impact on alanine aminotransferase levels.", "results_summary": "The combination therapy improved glycated hemoglobin, hepatic steatosis, hepatic stiffness, and alanine aminotransferase levels compared to monotherapy, while also reducing weight gain and inducing cardioprotective effects.", "population_specificity": "Patients with NAFLD and T2DM with a hepatic fat fraction of \u226510%.", "effective_dosage": "20 mg tofogliflozin or 15-30 mg pioglitazone orally, once daily.", "study_duration": "24 weeks of monotherapy followed by 24 weeks of combination therapy (total 48 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:32.802257+00:00"}
{"study_id": 102868, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of direct-acting antiviral (DAA) regimens, including the role of elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as predictors for non-sustained virologic response (non-SVR) in chronic hepatitis C patients.", "results_summary": "Elevated ALT and AST at baseline were specifically associated with non-SVR in patients with genotype 3 and 6 infections, with baseline AST being the best predictor for SVR in these genotypes. The study did not focus on alanine as a supplement but rather as a biomarker.", "population_specificity": "Chronic hepatitis C patients in Guangdong, China, with multiple genotypes circulating.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:34.905329+00:00"}
{"study_id": 102869, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not investigate Alanine; it focuses on pembrolizumab's efficacy and safety in NSCLC patients with poor performance status and high PD-L1 expression.", "results_summary": "The study does not report findings related to Alanine; it discusses pembrolizumab's effects, including adverse events like elevated alanine aminotransferase levels.", "population_specificity": "Non-small-cell lung cancer (NSCLC) patients with poor performance status (PS 2-3) and PD-L1 expression \u226550%.", "effective_dosage": "Not mentioned (study does not focus on Alanine).", "study_duration": "Not mentioned (study does not focus on Alanine).", "interactions": "None mentioned (study does not focus on Alanine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:35.969618+00:00"}
{"study_id": 102871, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to derive contextual comparator data for clinical trials of intestinal bile acid transport inhibitors in Alagille syndrome (ALGS) by analyzing real-world data from a natural history cohort.", "results_summary": "The study found no significant changes in alanine aminotransferase levels over a 2-year follow-up in the ALGS natural history cohort, while pruritus significantly decreased and platelet count dropped significantly.", "population_specificity": "Children with cholestasis and Alagille syndrome (ALGS) with their native liver.", "effective_dosage": "Not available", "study_duration": "2 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:37.168277+00:00"}
{"study_id": 102870, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study aimed to evaluate the efficacy and safety of Lenvatinib (LEN) as a first-line treatment for patients with hepatocellular carcinoma (HCC) at BCLC substage B2, not Alanine.", "results_summary": "The study found that LEN had a 1-year survival rate of 71.0%, median overall survival of 17.0 months, and common adverse events included fatigue, hypertension, and anorexia. No results regarding Alanine were reported.", "population_specificity": "Patients with HCC at BCLC substage B2 and preserved hepatic function.", "effective_dosage": "Not mentioned (study focused on LEN, not Alanine).", "study_duration": "2-year enrollment period and 10-month follow-up.", "interactions": "None mentioned (study focused on LEN, not Alanine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:37.585750+00:00"}
{"study_id": 102872, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study evaluated the efficacy and safety of anlotinib plus TQB2450 in advanced biliary tract cancers, not Alanine.", "results_summary": "The study found that anlotinib plus TQB2450 showed promising efficacy in advanced biliary tract cancers, with an objective response rate of 21.21% and a disease control rate of 72.73%. Adverse events were common, with elevated alanine aminotransferase reported in 6.06% of patients.", "population_specificity": "Patients with advanced biliary tract cancers who had progressed or declined or were ineligible for first-line chemotherapy.", "effective_dosage": "Not mentioned for Alanine.", "study_duration": "Median follow-up was 19.68 months.", "interactions": "None mentioned for Alanine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:39.256385+00:00"}
{"study_id": 102875, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to investigate whether reducing sedentary behavior improves cardiometabolic biomarkers in adults with metabolic syndrome, not specifically related to Alanine.", "results_summary": "The study found that reducing sedentary behavior by 50 min/day and increasing light-intensity and moderate-to-vigorous physical activity improved several cardiometabolic biomarkers, such as fasting insulin and insulin resistance, in adults with metabolic syndrome. No direct results related to Alanine were reported.", "population_specificity": "Sedentary middle-aged adults with metabolic syndrome (n=64).", "effective_dosage": "Not mentioned", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:40.303632+00:00"}
{"study_id": 102873, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to explore the frequencies and diagnostic predictors of priority infections causing persistent fever in tropical regions, with elevated alanine aminotransferase levels identified as a predictor for enteric fever and rickettsiosis.", "results_summary": "Elevated alanine aminotransferase levels were found to have a positive likelihood ratio \u22653 for enteric fever and rickettsiosis, indicating its diagnostic relevance for these infections. The study did not evaluate alanine as a supplement or therapeutic agent.", "population_specificity": "Patients aged 5 years or older with persistent fever in tropical regions (Sudan, DRC, Nepal, Cambodia).", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:40.771995+00:00"}
{"study_id": 102874, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the influence of a ketogenic diet (KD) on serum levels of leptin, chemerin, and resistin in children with drug-resistant epilepsy (DRE), including measurements of alanine aminotransferase activity as part of biochemical tests.", "results_summary": "The study found that serum levels of leptin and chemerin were significantly lower, and resistin higher, in children on KD compared to those on valproic acid (VPA) and controls. Alanine aminotransferase activity was measured but specific results regarding its changes were not highlighted in the abstract.", "population_specificity": "72 children aged 3-9 years, divided into groups with DRE treated with KD, DRE treated with VPA, and a control group.", "effective_dosage": "Not specified for alanine.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:42.397709+00:00"}
{"study_id": 102876, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine the frequency of liver blood tests, including alanine aminotransferase (ALT), in primary care populations in Wales and examine their variation by age and sex.", "results_summary": "The study found that ALT testing increased from 2% to 33% of the population over 18 years, with values varying by age and sex, particularly in males where upper normal ranges decreased with age. The reduction in AST testing limited the use of non-invasive liver marker algorithms.", "population_specificity": "Adult patients in Wales with at least one blood test available (2,145,178 individuals).", "effective_dosage": "Not available", "study_duration": "18 years (2000-2017)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:43.448195+00:00"}
{"study_id": 102877, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to analyze published cases of autoimmune hepatitis (AIH) following COVID-19 vaccination, including characteristic findings, treatment, and outcomes.", "results_summary": "The study identified 32 cases of AIH-like syndromes post-vaccination, with jaundice as the most common symptom (81%). Most patients (97%) showed improvement or complete resolution with steroid treatment, though one fatality occurred.", "population_specificity": "Individuals who developed AIH-like syndromes after COVID-19 vaccination.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:44.834781+00:00"}
{"study_id": 102878, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to develop and validate a score (SAFE) to assess liver fibrosis in NAFLD patients using widely available variables, including alanine aminotransferase.", "results_summary": "The SAFE score, incorporating alanine aminotransferase among other variables, effectively distinguished liver fibrosis stages (\u2265F2 vs. F0/1) with high accuracy (AUC \u22650.80) and strong negative predictive values (88-92%). Higher SAFE scores correlated with shorter long-term survival in NAFLD patients.", "population_specificity": "Patients with biopsy-proven NAFLD from clinical studies and NHANES III participants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:45.400833+00:00"}
{"study_id": 102879, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the incidence of hepatotoxicity, including elevated alanine aminotransferase (ALT), among cancer patients receiving systemic therapy with and without immune checkpoint blockade (ICB).", "results_summary": "The study found that adding ICB to systemic therapy significantly increased the incidence of elevated ALT (any grade: OR, 2.01; grade 3-5: OR, 2.40), indicating higher hepatotoxicity risk. No direct assessment of alanine's therapeutic or adverse effects was conducted.", "population_specificity": "Cancer patients participating in phase 3 randomized controlled trials (RCTs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:46.236852+00:00"}
{"study_id": 102880, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study aimed to evaluate the efficacy and adverse events of favipiravir in patients with COVID-19, not specifically Alanine.", "results_summary": "The study did not focus on Alanine but reported increased alanine aminotransferase as an adverse event in favipiravir-treated patients.", "population_specificity": "Hospitalized and non-hospitalized patients with COVID-19.", "effective_dosage": "Not mentioned for Alanine.", "study_duration": "Not mentioned for Alanine.", "interactions": "None mentioned for Alanine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:46.884293+00:00"}
{"study_id": 102882, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the glycemic index (GI) and factors predicting individual glucose response to a new complete nutrition drink containing retrograded starch.", "results_summary": "The study found that the complete nutrition drink had a low GI (48.2 \u00b1 10.4 and 46.7 \u00b1 12.7 with glucose and white bread as references, respectively), but individual glucose responses varied widely (GI: 7-149).", "population_specificity": "Eighteen healthy volunteers with fasting plasma glucose (FPG) < 100 mg/dl.", "effective_dosage": "Not specified", "study_duration": "Single administration with 14-day wash-out intervals between interventions.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:50.704213+00:00"}
{"study_id": 102883, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare clinical and pathologic characteristics between AFP-positive and AFP-negative hepatocellular carcinoma (HCC) patients, including the role of alanine aminotransferase (ALT) as a biomarker.", "results_summary": "The study found that HCC patients with high serum AFP levels also had elevated ALT levels, among other biomarkers, suggesting a potential association between AFP status and liver function markers like ALT. However, the study did not specifically evaluate the efficacy or safety of alanine supplementation.", "population_specificity": "HCC patients from Eastern and Southern China, including those with decompensated hepatic cirrhosis, chronic hepatitis B, and HBV asymptomatic carriers.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:52.018355+00:00"}
{"study_id": 102881, "supplement_id": 863, "safety_score": "65", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary anticancer activity of eftozanermin alfa (eftoza) in patients with advanced solid tumors.", "results_summary": "The study found that eftoza had acceptable safety, with common adverse events including increased alanine aminotransferase and aspartate aminotransferase levels, nausea, and fatigue. Preliminary anticancer activity was observed, with partial responses in some patients, and pharmacodynamic effects were noted in circulation and tumor tissue.", "population_specificity": "Patients with advanced solid tumors, including colorectal cancer (CRC) and pancreatic cancer (PaCA).", "effective_dosage": "2.5-15 mg/kg intravenously on day 1 or day 1/day 8 every 21 days (dose-escalation phase); 1.25-7.5 mg/kg once-weekly (dose-optimization phase).", "study_duration": "Not explicitly stated, but follow-up included the first treatment cycle for DLT evaluation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:52.179105+00:00"}
{"study_id": 102884, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare real-world outcomes of tenofovir alafenamide (TAF) with other first-line regimens (TDF and entecavir) for chronic hepatitis B (CHB), focusing on efficacy and safety.", "results_summary": "At 24 months, TAF showed superior efficacy with a higher percentage of patients achieving HBV DNA suppression (93% vs. 86%) and normalized ALT levels (66% vs. 56%) compared to TDF, while maintaining stable eGFR. However, a higher percentage of patients with eGFR <60 ml/min/1.73 m\u00b2 was noted in the TAF group.", "population_specificity": "Patients with chronic hepatitis B (CHB) from 10 centers, mean age 52, 72% HBeAg-negative.", "effective_dosage": "Not specified", "study_duration": "24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:53.061167+00:00"}
{"study_id": 102885, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the diagnostic accuracy of non-invasive methods, including alanine aminotransferase (ALT), with liver biopsy for detecting and staging NAFLD in obese individuals undergoing bariatric surgery.", "results_summary": "The study found that ALT, as part of the HAIR score, had an accuracy of 40.23% for detecting steatohepatitis, which was lower compared to other markers like APRI and NFS for advanced fibrosis. Liver biopsy remained the most accurate and safe method for diagnosing NAFLD in this population.", "population_specificity": "Obese individuals undergoing bariatric surgery (87.5% female, mean age 34.9\u00b19.7 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:53.408405+00:00"}
{"study_id": 102886, "supplement_id": 863, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of sebelipase alfa (a recombinant form of lysosomal acid lipase) in patients with lysosomal acid lipase deficiency (LAL-D).", "results_summary": "Sebelipase alfa treatment led to sustained improvements in liver and lipid parameters, including reduced ALT and AST levels, improved liver and spleen volumes, and favorable changes in cholesterol levels. The treatment was well tolerated, with mostly mild or moderate infusion-associated reactions and no severe adverse effects directly linked to the therapy.", "population_specificity": "Patients >8 months of age diagnosed with LAL-D.", "effective_dosage": "1.0 mg/kg every other week (qow), with possible escalation to 3.0 mg/kg qow or weekly, or reduction to 0.35 mg/kg qow for tolerability.", "study_duration": "Up to 144 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:55.002707+00:00"}
{"study_id": 102887, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine the safety, tolerability, and pharmacokinetics of rezafungin after subcutaneous administration in healthy adults.", "results_summary": "The study reported increased alanine aminotransferase and sinus bradycardia as common adverse events, generally mild to moderate and not rezafungin-related. The study was terminated after the 10 mg dose cohort due to concerns about injection site reactions, but no predetermined halting criteria were met.", "population_specificity": "Healthy adults", "effective_dosage": "Single doses of 1, 10, 30, 60, 100, or 200 mg", "study_duration": "Single dose administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:55.317622+00:00"}
{"study_id": 102888, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess the prevalence and associated factors of liver steatosis and advanced fibrosis in HIV-monoinfected patients at risk of NAFLD.", "results_summary": "The study found that steatosis was present in two-thirds of the HIV-monoinfected patients at risk of NAFLD, and around 10% had advanced fibrosis. The CAP technique was deemed accurate for screening steatosis in this population.", "population_specificity": "HIV-monoinfected patients, nonexcessive drinkers with metabolic syndrome, and/or persistently elevated liver enzymes, and/or clinical lipodystrophy.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:55.730188+00:00"}
{"study_id": 102889, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the efficacy and safety of tofacitinib in refractory polyarticular course juvenile idiopathic arthritis (JIA) patients, not specifically Alanine.", "results_summary": "The study found significant improvement in disease activity scores (JADAS 27) in most JIA subtypes, with 70.4% of cases achieving inactive disease at 24 weeks. Side effects like elevated alanine aminotransferase were noted but improved over time.", "population_specificity": "Refractory polyarticular course juvenile idiopathic arthritis (JIA) patients (n=27).", "effective_dosage": "Recommended doses of tofacitinib (specific amounts not detailed in abstract).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:35:59.945801+00:00"}
{"study_id": 102890, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the prevalence, clinical patterns, and risk factors for tigecycline-induced liver injury, with a focus on abnormal baseline alanine aminotransferase levels as a risk factor.", "results_summary": "The study found that 10.3% of patients developed tigecycline-induced liver injury, primarily cholestatic and mild in severity. Abnormal baseline alanine aminotransferase levels were identified as an independent risk factor (OR = 3.11).", "population_specificity": "Inpatients receiving intravenous tigecycline for \u22657 days.", "effective_dosage": "Not specified", "study_duration": "\u22657 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:00.719164+00:00"}
{"study_id": 102891, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to compare the overall survival and safety of pembrolizumab versus chemotherapy in patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer, not specifically focused on Alanine.", "results_summary": "The study found that pembrolizumab showed durable antitumour activity and fewer treatment-related adverse events compared to chemotherapy, but no significant difference in overall survival was observed. Increased alanine aminotransferase was noted as a common adverse event in the pembrolizumab group.", "population_specificity": "Patients aged at least 18 years with previously untreated microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer.", "effective_dosage": "Not applicable (study focused on pembrolizumab and chemotherapy, not Alanine).", "study_duration": "Median follow-up of 44.5 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:02.222281+00:00"}
{"study_id": 102892, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effects of Camelina sativa oil (CSO), a source of omega-3 fatty acids and antioxidants, on liver enzymes (including alanine aminotransferase), lipid profile, and adiponectin in NAFLD patients.", "results_summary": "CSO supplementation significantly improved weight, BMI, waist circumference, lipid profile (except HDL-c), atherogenic index, alanine aminotransferase (ALT), and adiponectin levels compared to placebo. No significant changes were observed in hip circumference, neck circumference, HDL-c, or other liver enzymes.", "population_specificity": "46 patients with nonalcoholic fatty liver disease (NAFLD)", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:02.225293+00:00"}
{"study_id": 102893, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the relationship between quantitative hepatitis B core antibody (qAnti-HBc) and hepatic histological inflammation in chronic hepatitis B (CHB) patients with normal or mildly elevated alanine transaminase (NMALT) levels.", "results_summary": "The study found that qAnti-HBc was positively associated with liver inflammation in treatment-naive CHB patients, with a 56% increased risk of moderate to severe inflammation per standard deviation increase in qAnti-HBc. A significant threshold effect was observed at 4.5 log.", "population_specificity": "Treatment-naive chronic hepatitis B (CHB) patients with normal or mildly elevated alanine transaminase (NMALT) levels from 34 Chinese hospitals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:03.584821+00:00"}
{"study_id": 102895, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the efficacy, safety, and persistence of teriflunomide in relapsing-remitting multiple sclerosis (RRMS) patients, with incidental mention of alanine aminotransferase (ALT) elevation as an adverse event.", "results_summary": "The study found that ALT elevation was one of the most frequent adverse events leading to teriflunomide discontinuation, but it did not specifically assess the safety or efficacy of alanine itself.", "population_specificity": "217 consecutive teriflunomide-treated RRMS patients, with 192 having at least 3-month persistence.", "effective_dosage": "Not specified for alanine.", "study_duration": "Follow-up at 6, 12, and 24 months after teriflunomide initiation.", "interactions": "None mentioned for alanine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:04.002281+00:00"}
{"study_id": 102896, "supplement_id": 863, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether monotherapy with AnluoHuaxian pill (AHP) improves liver histology in chronic hepatitis B (CHB) patients with alanine aminotransferase (ALT) levels less than 2 times the upper limit of normal and early liver fibrosis.", "results_summary": "The study found that AHP significantly improved liver fibrosis compared to placebo, with a higher rate of histologic improvement (37.7% vs. 19.5%) and reduced liver stiffness measurement. No serious side effects were reported in the AHP group.", "population_specificity": "CHB patients with ALT<2ULN and early liver fibrosis (F \u2264 2).", "effective_dosage": "Not specified in the abstract.", "study_duration": "48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:04.232673+00:00"}
{"study_id": 102897, "supplement_id": 863, "safety_score": "65", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and safety of vupanorsen (not Alanine) in reducing non-HDL-C and other lipid parameters in adults with elevated non-HDL-C and triglycerides on statin therapy.", "results_summary": "Vupanorsen significantly reduced non-HDL-C (22.0% to 27.7%) and other lipid parameters, but higher doses were associated with increased injection site reactions, liver enzyme elevations, and hepatic fat fraction.", "population_specificity": "Adults with non-HDL-C \u2265100 mg/dL and triglycerides 150-500 mg/dL on statin therapy.", "effective_dosage": "80, 120, or 160 mg SC every 4 weeks, or 60, 80, 120, or 160 mg SC every 2 weeks.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:09.299112+00:00"}
{"study_id": 102900, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the efficacy and application value of plasma exchange as an adjuvant therapy in children with hemophagocytic syndrome (HPS).", "results_summary": "Plasma exchange as an adjuvant therapy improved clinical symptoms, signs, and some laboratory markers in children with severe HPS, and shortened their PICU stay.", "population_specificity": "Forty children with severe HPS treated in the pediatric intensive care unit (PICU) of Hunan Children's Hospital.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:10.502218+00:00"}
{"study_id": 102898, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the efficacy of plasma exchange (PE) alone versus combined double plasma molecular absorption system (DPMAS) and PE in treating acute-on-chronic liver failure (ACLF), including effects on alanine aminotransferase (ALT) levels.", "results_summary": "The study found that DPMAS combined with PE significantly reduced ALT levels compared to PE alone, indicating improved liver function. However, no significant changes were observed in other markers like TBIL, ALB, Cr, or PLT.", "population_specificity": "Patients with acute-on-chronic liver failure (ACLF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:10.628249+00:00"}
{"study_id": 102899, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to identify the recommended dose for expansion/maximum tolerated dose of IDH305, a mutant-selective IDH1 inhibitor, in patients with IDH1-mutated advanced malignancies.", "results_summary": "IDH305 showed rapid absorption but the study was prematurely halted due to a potentially narrow therapeutic window, and no recommended phase 2 dose was declared.", "population_specificity": "41 patients with IDH1-mutated advanced malignancies.", "effective_dosage": "75-750 mg twice daily.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:10.958105+00:00"}
{"study_id": 102901, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to study the protective effect of branched-chain amino acids (BCAAs), including alanine, on muscle injury in aerobics athletes after endurance exercise.", "results_summary": "The study found that BCAA supplementation helped reduce blood glucose levels post-exercise, increased lactate dehydrogenase and alanine aminotransferase levels in the intervention group, and suggested that longer exercise durations made BCAA supplementation more effective. Alanine levels decreased in both groups after exercise.", "population_specificity": "32 aerobics athletes (16 in the intervention group, 16 in the control group).", "effective_dosage": "Not specified", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:13.305326+00:00"}
{"study_id": 102902, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the feasibility and safety of solo-surgeon pure laparoscopic donor nephrectomy, not Alanine.", "results_summary": "The study found that solo-surgeon pure laparoscopic donor nephrectomy was technically feasible (100% success rate) but noted intraoperative and postoperative complications, including spleen injury and nausea/vomiting, unrelated to Alanine.", "population_specificity": "Potential candidates for laparoscopic donor nephrectomy (40 enrolled out of 47 screened).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:13.420368+00:00"}
{"study_id": 102903, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of lenvatinib and sorafenib as first-line systemic therapy for unresectable hepatocellular carcinoma (uHCC) in chronic hepatitis B patients, focusing on overall survival, progression-free survival, time to progression, and tumor response.", "results_summary": "The study found that lenvatinib had comparable overall survival and progression-free survival to sorafenib but demonstrated significantly longer time to progression and better tumor response rates (higher objective response and disease control rates).", "population_specificity": "132 patients with HBV-related unresectable hepatocellular carcinoma (uHCC).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:14.673373+00:00"}
{"study_id": 102894, "supplement_id": 863, "safety_score": "70", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and preliminary efficacy of sabizabulin, an oral cytoskeleton disruptor, in men with metastatic castration-resistant prostate cancer (mCRPC).", "results_summary": "The study found that sabizabulin had a favorable safety profile with predominantly grade 1-2 adverse events, including alanine aminotransferase/aspartate aminotransferase elevations (5.6% and 3.7%, respectively). Preliminary efficacy data showed an objective response rate of 20.7% in patients with measurable disease and a median radiographic progression-free survival of 11.4 months.", "population_specificity": "Men with metastatic castration-resistant prostate cancer (mCRPC), including those with prior androgen receptor-targeting agent treatment and no prior chemotherapy.", "effective_dosage": "63 mg/day (recommended phase II dose).", "study_duration": "Duration varied, with durable responses lasting >2.75 years observed.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:15.827443+00:00"}
{"study_id": 102904, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify metabolic biomarkers and pathways, including Alanine metabolism, associated with myopia to understand disease mechanisms and potential therapeutic targets.", "results_summary": "The study found that Alanine, aspartate, and glutamate metabolism was one of the significantly enriched pathways in high myopia, suggesting a potential role in the disease's metabolic profile.", "population_specificity": "Human and animal studies (seven human and two animal studies).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:16.243709+00:00"}
{"study_id": 102907, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the prevalence of elevated liver chemistries, including alanine aminotransferase (ALT), in hospitalized COVID-19 patients and their association with disease severity and mortality.", "results_summary": "The study found that 70.4% of patients had abnormal ALT levels at admission, which were associated with disease severity and higher mortality risk. Elevated ALT, along with other liver markers, was linked to the need for advanced therapies like vasopressors and mechanical ventilation.", "population_specificity": "3380 hospitalized COVID-19 patients in the Johns Hopkins Health System.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:18.841310+00:00"}
{"study_id": 102905, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of dapagliflozin in improving liver function parameters and metabolic outcomes in patients with nonalcoholic fatty liver disease (NAFLD).", "results_summary": "Dapagliflozin significantly reduced alanine aminotransferase (ALT) and aspartate aminotransaminase (AST) levels, improved insulin resistance (HOMA-IR), and reduced body weight and BMI, but had a non-significant effect on gamma-glutamyl transferase (GGT) and increased total cholesterol.", "population_specificity": "Patients with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:18.869451+00:00"}
{"study_id": 102906, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to examine the impact of rosemary leaf powder, in conjunction with a weight loss diet, on liver function and biochemical parameters in patients with nonalcoholic fatty liver disease.", "results_summary": "Both the rosemary and placebo groups showed significant improvements in liver enzymes, metabolic markers, and anthropometric indices after 8 weeks, but there was no statistically significant difference between the groups except for homeostasis model assessment of \u03b2-cell dysfunction. The study concluded that rosemary did not produce effects significantly different from the diet/activity intervention alone.", "population_specificity": "Patients with nonalcoholic fatty liver disease (n=110).", "effective_dosage": "4 g rosemary leaf powder daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:19.182137+00:00"}
{"study_id": 102908, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the efficacy and safety of DA-2802 (a formulation containing Alanine) versus Viread in patients with chronic hepatitis B (CHB).", "results_summary": "The study found that DA-2802 was effective and safe for treating CHB, with comparable outcomes to Viread. The results suggest DA-2802 is a viable alternative for CHB treatment.", "population_specificity": "Patients with chronic hepatitis B (CHB) recruited from 25 hospitals in Korea.", "effective_dosage": "319 mg once daily", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:20.785573+00:00"}
{"study_id": 102909, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers reviewed the efficacy and safety of tenofovir disoproxil fumarate (TDF) in preventing HBV mother-to-child transmission and discussed changes in maternal viral markers, including alanine aminotransferase (ALT), postpartum.", "results_summary": "The abstract does not provide specific results regarding alanine or alanine aminotransferase (ALT) effects, only mentioning its inclusion in the review of maternal viral markers post-partum.", "population_specificity": "Pregnant women with high HBV-DNA levels (>200,000 IU/ml) receiving nucleos(t)ide analogue (NA) treatment to prevent vertical HBV transmission.", "effective_dosage": "Not specified for alanine/ALT.", "study_duration": "Third trimester of pregnancy (for NA treatment).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:22.466398+00:00"}
{"study_id": 102911, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to establish links between COSIAM parameters (whole-body muscle mass, muscle protein synthesis, and breakdown) and muscle function in older adults.", "results_summary": "The abstract does not provide specific results regarding Alanine's effects, only mentioning the study's focus on muscle vitality diagnostics and recruitment of participants.", "population_specificity": "37 healthy older adults (21 male, 16 female; age 72 \u00b1 5 years).", "effective_dosage": "Not specified", "study_duration": "3-day trial", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:22.969550+00:00"}
{"study_id": 102912, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of konjaku flour (KF) supplementation on treating obesity and regulating intestinal microbiota in obese adults, including its impact on alanine aminotransferase (ALT) levels.", "results_summary": "KF supplementation significantly reduced ALT levels, along with BMI, fat mass, blood glucose, and blood lipid levels, while improving hepatic function and regulating gut microbiota.", "population_specificity": "Obese adults aged 25-35 with BMI \u226528 kg/m\u00b2.", "effective_dosage": "Not specified", "study_duration": "5 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:23.865635+00:00"}
{"study_id": 102910, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were evaluating the effects of CDK4/6 inhibitors combined with neoadjuvant endocrine treatment (NET) versus NET or neoadjuvant chemotherapy (NACT) alone in ER+/HER2- early breast cancer patients, including the impact on alanine aminotransferase (ALT) levels as an adverse effect.", "results_summary": "The study found that CDK4/6 inhibitors plus NET increased the risk of elevated ALT levels as a grade 3/4 adverse effect but did not focus on alanine's therapeutic or safety profile. The combination showed no significant improvement in key efficacy outcomes like PEPI-0 rate, pCR rate, ORR, or DCR.", "population_specificity": "Patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2-) early breast cancer.", "effective_dosage": "Not specified for alanine.", "study_duration": "Not specified for alanine.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:24.401223+00:00"}
{"study_id": 102916, "supplement_id": 863, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety, tolerability, anti-tumor activity, and pharmacokinetics of D-0316, a third-generation EGFR-TKI, in patients with locally advanced or metastatic NSCLC harboring the EGFR T790M mutation.", "results_summary": "D-0316 was well tolerated with mostly grade 1 or 2 adverse events, demonstrated anti-tumor activity with overall response rates of 33.3% (50 mg) and 45.5% (100 mg), and showed dose-proportional exposure. The recommended phase II dose was 100 mg.", "population_specificity": "Patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR T790M mutation who progressed after prior EGFR-TKI treatment.", "effective_dosage": "25 to 150 mg daily (dose-escalation), 50 and 100 mg daily (dose-expansion).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:30.491934+00:00"}
{"study_id": 102918, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to develop a prognostic model for adult HLH in China, identifying alanine aminotransferase as one of the independent prognostic factors.", "results_summary": "The study found that alanine aminotransferase was an independent prognostic factor for adult HLH, contributing to a scoring model that stratified patients into risk groups with varying survival rates.", "population_specificity": "270 newly diagnosed adult HLH patients in China.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:30.976106+00:00"}
{"study_id": 102913, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study aimed to evaluate the efficacy and safety of valoctocogene roxaparvovec, a gene therapy for severe hemophilia A, not specifically Alanine.", "results_summary": "The study found that valoctocogene roxaparvovec increased factor VIII activity levels and reduced bleeding and factor VIII concentrate use, with common adverse events including elevated alanine aminotransferase levels.", "population_specificity": "Men with severe hemophilia A (factor VIII level \u22641 IU/dL), aged \u226518 years, without preexisting anti-AAV5 antibodies or history of factor VIII inhibitors.", "effective_dosage": "Single infusion of 6\u00d710^13 vg/kg (exact dosage not specified for Alanine).", "study_duration": "Follow-up of more than 51 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:31.323483+00:00"}
{"study_id": 102919, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to evaluate the tolerability, safety, and efficacy of vorolanib when combined with checkpoint inhibitors in patients with advanced solid tumors, not specifically Alanine.", "results_summary": "The study reported alanine aminotransferase elevation as a common treatment-related adverse event but did not focus on Alanine's effects.", "population_specificity": "Patients with advanced gastrointestinal or lung cancers.", "effective_dosage": "Not applicable (study focused on vorolanib, not Alanine).", "study_duration": "Not specified for Alanine.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:31.481906+00:00"}
{"study_id": 102917, "supplement_id": 863, "safety_score": "70", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and feasibility of taminadenant (an A2AR antagonist) with or without spartalizumab in patients with advanced NSCLC, including monitoring for adverse effects like alanine/aspartate aminotransferase increases.", "results_summary": "The study found that taminadenant, alone or combined with spartalizumab, was generally well tolerated, with dose-limiting toxicities including alanine/aspartate aminotransferase increases. Some clinical benefit was observed, including partial and complete responses, though efficacy was not a primary endpoint.", "population_specificity": "Patients with advanced/metastatic non-small cell lung cancer (NSCLC) who had received at least one prior therapy.", "effective_dosage": "Taminadenant (80-640 mg, orally, twice a day); spartalizumab (400 mg, i.v., every 4 weeks).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:32.421237+00:00"}
{"study_id": 102920, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy of stereotactic body radiotherapy (SBRT) plus pembrolizumab and trametinib in patients with locally recurrent pancreatic cancer, not specifically focused on Alanine.", "results_summary": "The study found that SBRT plus pembrolizumab and trametinib improved median overall survival compared to SBRT plus gemcitabine, with increased alanine aminotransferase or aspartate aminotransferase as common adverse effects. No treatment-related deaths occurred.", "population_specificity": "Patients aged 18+ with histologically confirmed pancreatic ductal adenocarcinoma, mutant KRAS, PD-L1 positive, ECOG performance status 0-1, and documented local recurrence after surgery and chemotherapy.", "effective_dosage": "Not specified for Alanine.", "study_duration": "Median follow-up was 13.1 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:33.707438+00:00"}
{"study_id": 102922, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether blood concentrations of alanine and other amino acids correlate with neuropsychological performance after acute exercise.", "results_summary": "The study found that amino acid blood concentrations, including alanine, were significantly elevated post-exercise, and cognitive performance improved on specific neuropsychological assessments. A significant interaction effect was observed for the Trail Making Test part-B.", "population_specificity": "Sixty basketball players (exercise or inactive resting groups).", "effective_dosage": "Not specified", "study_duration": "Acute (single session)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:38.494518+00:00"}
{"study_id": 102924, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore biomarkers, including alanine aminotransferase (ALAT), to predict unbound plasma-to-tissue drug distribution in critically ill patients with sepsis.", "results_summary": "The study suggests that biomarkers like ALAT could help predict drug distribution and optimize antibiotic dosing in sepsis, potentially reducing resistance and mortality, but does not report specific findings on ALAT's effects.", "population_specificity": "Critically ill patients with sepsis", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:39.237277+00:00"}
{"study_id": 102921, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to analyze the effectiveness of cell- and G-CSF-based therapies, including their impact on alanine aminotransferase levels, in treating cirrhosis.", "results_summary": "The study found that cell-based and G-CSF-based therapies improved transplantation-free survival rates but demonstrated no obvious improvement in liver injury indicators, including alanine aminotransferase levels. G-CSF combined with EPO and GH showed therapeutic advantages in some outcomes.", "population_specificity": "Patients with cirrhosis.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:39.368253+00:00"}
{"study_id": 102923, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify significant metabolites and metabolic pathways, including alanine metabolism, associated with reproductive failures (early miscarriage, recurrent miscarriage, and repeated implantation failure).", "results_summary": "Alanine, aspartate, and glutamate metabolism had the highest impact factor in repeated implantation failure (RIF), suggesting a potential role in reproductive failure pathophysiology. The study did not establish causality or therapeutic efficacy of alanine supplementation.", "population_specificity": "Women with reproductive failures (early miscarriage, recurrent miscarriage, and repeated implantation failure).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:39.597264+00:00"}
{"study_id": 102914, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers were investigating the combination of nivolumab and cabozantinib in treating recurrent endometrial cancer, not specifically studying Alanine.", "results_summary": "The study found that elevated alanine aminotransferase (42%) was a common treatment-related adverse event in Arm A, but the focus was on cancer treatment outcomes, not Alanine's effects.", "population_specificity": "Women with recurrent endometrial cancer, including immunotherapy-na\u00efve patients and those with prior immunotherapy progression.", "effective_dosage": "Not mentioned (study focused on nivolumab and cabozantinib dosing).", "study_duration": "Not specified (follow-up duration not detailed in the abstract).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:39.650417+00:00"}
{"study_id": 102915, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and early outcomes of autologous bone marrow mononuclear cell infusion for liver cirrhosis due to biliary atresia, including monitoring alanine aminotransferase levels.", "results_summary": "The study found that autologous BMMNC administration was safe and may maintain or improve liver function, as indicated by monitored serum markers including alanine aminotransferase.", "population_specificity": "Children with liver cirrhosis due to biliary atresia after Kasai operation.", "effective_dosage": "Not specified for alanine; MNC and CD34+ cell counts per kg body weight were 50.1 \u00b1 58.5 \u00d7 10^6 and 0.6 \u00b1 0.5 \u00d7 10^6, respectively.", "study_duration": "12 months (with repeated procedure at 6 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:40.381258+00:00"}
{"study_id": 102925, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether recombinant human growth hormone (rhGH) treatment could improve non-alcoholic fatty liver disease (NAFLD) and related metabolic complications in obese boys.", "results_summary": "The study found that rhGH treatment significantly reduced liver enzymes (ALT, AST, GGT), improved lipid profiles (LDL-C, HDL-C), and decreased inflammatory markers (CRP) and BMI SDS in obese boys with NAFLD. No significant changes were observed in total cholesterol, triglycerides, or uric acid.", "population_specificity": "44 obese boys with NAFLD (aged 11.76 \u00b1 1.67 years).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:42.395167+00:00"}
{"study_id": 102926, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the epidemiological and clinical characteristics of SFTSV-infected patients, including the role of AST/ALT-ratio as a prognostic risk factor.", "results_summary": "The study found that elevated AST/ALT-ratio was an independent risk factor for poor prognosis in SFTS patients, and ribavirin treatment could decrease this ratio while increasing platelet counts.", "population_specificity": "107 hospitalized patients with SFTSV infection (mean age 60.38 \u00b1 11.29 years, male-to-female ratio 1:1.2).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:43.223290+00:00"}
{"study_id": 102927, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential role of the Aryl hydrocarbon Receptor (AhR) in modulating COVID-19's inflammatory response, including its regulation of ACE-2 and the Broad neutral Amino acid Transporter 1 (B0AT1), which involves alanine.", "results_summary": "The abstract suggests that AhR may be involved in managing COVID-19's inflammatory framework by regulating ACE-2 and B0AT1, but it does not provide specific findings on alanine's effects.", "population_specificity": "Not specified (general focus on COVID-19 inflammatory mechanisms).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:48.465853+00:00"}
{"study_id": 102929, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of enteral ecoimmunonutrition (EEIN), which includes alanine, in improving liver function, reducing inflammation, and enhancing immune response in patients undergoing hepatectomy.", "results_summary": "The study found that EEIN significantly reduced liver enzyme levels (alanine aminotransferase, aspartate transaminase), bilirubin, endotoxin, and inflammatory markers while improving immunoglobulin levels and accelerating postoperative gastrointestinal recovery.", "population_specificity": "Patients undergoing hepatectomy.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:50.330971+00:00"}
{"study_id": 102930, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize the types of HBV flares and associated immune responses, focusing on HBeAg-negative CHB patients, to improve management strategies.", "results_summary": "The abstract discusses HBV flares, their causes, and clinical outcomes but does not specifically evaluate alanine's effects. It highlights the immune response to HBV DNA and antigen surges, leading to ALT level spikes.", "population_specificity": "HBeAg-negative chronic hepatitis B (CHB) patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:50.925914+00:00"}
{"study_id": 102928, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the efficacy and safety of dapagliflozin in adults with nonalcoholic fatty liver disease (NAFLD).", "results_summary": "Dapagliflozin significantly reduced hepatic enzymes (alanine transaminase, aspartate transaminase, gamma-glutamyl transferase) and improved metabolic indicators (triglyceride, body weight, HbA1c, fasting plasma glucose) compared to controls, with no difference in adverse events.", "population_specificity": "Adults with NAFLD (839 patients across 11 studies).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:51.405701+00:00"}
{"study_id": 102932, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to examine the effects of ribavirin and sofosbuvir with silymarin on liver function markers, including alanine aminotransferase (ALT), in HCV patients.", "results_summary": "The abstract does not provide specific results regarding Alanine's effects, only mentioning it as one of the liver function markers studied.", "population_specificity": "30 HCV patients divided into two groups.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:52.150994+00:00"}
{"study_id": 102934, "supplement_id": 863, "safety_score": "80", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether losartan, which affects alanine aminotransferase (ALT) levels, could effectively treat pediatric NAFLD by reducing ALT levels compared to placebo.", "results_summary": "Losartan did not significantly reduce ALT levels in children with NAFLD compared to placebo, though it did significantly decrease alkaline phosphatase and systolic blood pressure. Adverse events and compliance were similar between groups.", "population_specificity": "Children aged 8-17 years with histologically confirmed NAFLD, predominantly male (81%) and Hispanic (80%).", "effective_dosage": "100 mg orally once daily", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:56.867528+00:00"}
{"study_id": 102933, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study evaluated the safety and efficacy of ledipasvir-sofosbuvir in adolescents with chronic HCV genotype 4 and hematological malignancies, not Alanine.", "results_summary": "The study found ledipasvir-sofosbuvir to be well-tolerated and efficacious, with all patients achieving sustained virologic response (SVR12). No HCV flares were reported.", "population_specificity": "Adolescents (ages 12-17) with chronic HCV genotype 4 infection undergoing maintenance chemotherapy for hematological malignancies.", "effective_dosage": "Ledipasvir-sofosbuvir (90 mg/400 mg) once daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:36:57.264826+00:00"}
{"study_id": 102938, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of ginger supplementation on fatty liver disease, including its impact on alanine aminotransferase (ALT) levels.", "results_summary": "Ginger supplementation significantly reduced serum levels of alanine aminotransferase (ALT) by -2.85 U/L, indicating potential liver function improvement. The study also noted reductions in other markers like AST, TG, LDL, and TC, alongside increased HDL.", "population_specificity": "The study included both in-vivo experiments (animal models) and clinical trials (human participants).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:01.334661+00:00"}
{"study_id": 102936, "supplement_id": 863, "safety_score": "20", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to investigate severe liver injury cases induced by multityrosine kinase inhibitors (MTKIs) like pazopanib and sunitinib, focusing on alanine aminotransferase (ALT) elevation as a marker of liver damage.", "results_summary": "The study reported severe liver injury in two metastatic renal cell carcinoma patients treated with pazopanib and sunitinib, marked by grade 4 ALT increase and hyperbilirubinemia, with one case resulting in fatal liver failure.", "population_specificity": "Metastatic renal cell carcinoma patients treated with pazopanib or sunitinib.", "effective_dosage": "Not specified", "study_duration": "3.5 years for sunitinib; pazopanib duration not specified", "interactions": "Clarithromycin co-medication was associated with fatal liver failure in one case.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:02.730248+00:00"}
{"study_id": 102937, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were attempting to determine the safety and efficacy of temsirolimus in combination with cyclophosphamide and etoposide for treating relapsed/refractory ALL in children and adolescents, not specifically Alanine.", "results_summary": "The study found that temsirolimus combined with cyclophosphamide and etoposide had an acceptable safety profile and demonstrated dose-dependent inhibition of the PI3K/mTOR pathway, with a 47% overall response rate and 27% complete response rate. Elevated alanine aminotransferase was noted as a grade 3/4 non-hematologic toxicity in some patients.", "population_specificity": "Children and adolescents with relapsed/refractory acute lymphoblastic leukemia (ALL).", "effective_dosage": "Temsirolimus doses ranged from 7.5 mg/m\u00b2 to 25 mg/m\u00b2 IV on days 1 and 8; cyclophosphamide 440 mg/m\u00b2 and etoposide 100 mg/m\u00b2 IV daily on days 1-5.", "study_duration": "The intervention was administered over 5 days per cycle (days 1-5 for cyclophosphamide and etoposide; days 1 and 8 for temsirolimus).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:04.650679+00:00"}
{"study_id": 102940, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the levels of alanine and other amino acids in the CSF of patients with MELAS syndrome compared to controls, to understand metabolic imbalances.", "results_summary": "The study found significantly higher CSF levels of alanine in MELAS patients compared to controls, suggesting an upregulation of the lactate-alanine cycle due to metabolic imbalance.", "population_specificity": "Nine adult patients with MELAS syndrome (66.7% female, mean age 35.8 years) and 19 controls (63.2% female, mean age 42.7 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:04.756219+00:00"}
{"study_id": 102939, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to analyze factors associated with insulin resistance (IR) in chronic HCV-infected patients and evaluate changes in glucose homeostasis after treatment with direct-acting antiviral agents (DAAs).", "results_summary": "High IR was observed in 35.1% of patients, with obesity, treatment experience, high serum ALT, triglycerides, and advanced fibrosis identified as independent factors. Viral elimination by DAAs led to a significant reduction in mean HOMA-IR in patients with baseline high IR, HCV genotype 1, and treatment experience.", "population_specificity": "704 patients with chronic HCV infection treated with interferon-free DAAs.", "effective_dosage": "Not specified", "study_duration": "12-weeks post-treatment", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:05.587790+00:00"}
{"study_id": 102931, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers were investigating the clinical activity of abemaciclib in patients with p16ink4A-negative mesothelioma, not specifically studying Alanine.", "results_summary": "The study reported increased alanine aminotransferase as a treatment-related adverse event in some patients, but Alanine was not the focus of the research.", "population_specificity": "Patients with p16ink4A-negative mesothelioma who had progressed after platinum-based chemotherapy.", "effective_dosage": "Not applicable (Alanine was not administered).", "study_duration": "Not applicable (Alanine was not administered).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:06.253046+00:00"}
{"study_id": 102941, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to systematically analyze hematologic toxicity in hematologic malignancies treated with CAR-T cell therapy, including the incidence of alanine transaminase (ALT) increase.", "results_summary": "The study found that ALT increase was one of the adverse effects observed in patients undergoing CAR-T cell therapy, but it did not focus on alanine as a supplement. The incidence of ALT increase was calculated among other hematologic toxicities.", "population_specificity": "Patients with hematologic malignancies undergoing CAR-T cell therapy.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:06.656834+00:00"}
{"study_id": 102942, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify potential metabolic biomarkers, including alanine, and pathways involved in epilepsy to aid in diagnosis, therapy, and understanding disease pathogenesis.", "results_summary": "The study found that alanine metabolism was one of the disturbed pathways in epilepsy, suggesting its potential role in the disease's pathogenesis, but did not specify direct effects of alanine supplementation.", "population_specificity": "Patients with epilepsy (PWE) and epileptic animal models.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:07.859180+00:00"}
{"study_id": 102935, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of aerobic exercise training, with or without diet, in improving liver function, insulin resistance, and lipid levels in adults with non-alcoholic fatty liver disease (NAFLD).", "results_summary": "The meta-analysis found significant improvements in alanine aminotransferase (ALT) levels and other liver function markers, suggesting aerobic exercise, with or without diet, is effective for NAFLD management.", "population_specificity": "Adults with non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "4 or more weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:08.789112+00:00"}
{"study_id": 102943, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of fish oil plus vitamin D supplementation on biomarkers of hepatocellular damage, including alanine aminotransferase (ALT), in subjects with NAFLD.", "results_summary": "The study found significant reductions in serum ALT levels in the FO + D and FO groups compared to the control group, with additional improvements in insulin levels and inflammation markers in the FO + D group.", "population_specificity": "111 subjects with NAFLD, aged 56.0 \u00b1 15.9 years.", "effective_dosage": "3 g/day of capsules providing 2.34 g/day of EPA + DHA + 1680 IU vitamin D.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:12.097570+00:00"}
{"study_id": 102944, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and tolerability of perioperative immunotherapy (nivolumab with or without ipilimumab) in patients with resectable hepatocellular carcinoma, not specifically Alanine.", "results_summary": "The study found increased alanine aminotransferase as a common treatment-related adverse event, but it did not assess Alanine's efficacy or safety as a supplement.", "population_specificity": "Patients with resectable hepatocellular carcinoma.", "effective_dosage": "Not applicable (study focused on immunotherapy, not Alanine).", "study_duration": "Up to 2 years (adjuvant phase).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:12.269278+00:00"}
{"study_id": 102945, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of different nutritional interventions, including those involving alanine (as part of branched-chain amino acids), in improving nutritional indicators and liver function in patients with cirrhosis.", "results_summary": "The study found that enteral nutrition (EN) with branched-chain amino acids was more effective than EN without them, and EN combined with intestinal probiotics appeared superior to other interventions, including PN+EN, for improving outcomes in cirrhosis patients.", "population_specificity": "Patients with liver cirrhosis.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:12.860832+00:00"}
{"study_id": 102947, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to identify key factors in the pathogenesis of metabolic alterations in obesity using machine learning technology.", "results_summary": "The abstract does not provide specific findings regarding Alanine's effects.", "population_specificity": "Patients with obesity (single-center study).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:13.467973+00:00"}
{"study_id": 102946, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize the identification of dengue B-cell epitopes within the envelope (E) protein, including approaches like mutagenesis/alanine scanning, to guide vaccine design and therapeutic development.", "results_summary": "The abstract highlights the use of alanine scanning among other methods to identify protective linear B-cell epitopes in the dengue E protein, which could inform peptide vaccine constructs and monoclonal antibody therapies. No specific results on alanine's effects are detailed.", "population_specificity": "Not specified (focus on dengue virus and vaccine/therapeutic development).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:13.645080+00:00"}
{"study_id": 102949, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to assess the effects of intravenous trehalose on arterial wall inflammation in human subjects with a history of myocardial infarction and systemic inflammation.", "results_summary": "The study found no significant reduction in arterial wall inflammation or changes in echocardiographic measurements after trehalose treatment. A significant difference was observed in alanine aminotransferase (ALT) levels between the trehalose and placebo groups.", "population_specificity": "15 patients with a history of myocardial infarction and systemic inflammation (C-reactive protein > 2 mg/L).", "effective_dosage": "15 g once weekly (intravenous).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:15.510152+00:00"}
{"study_id": 102948, "supplement_id": 863, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness and safety of Xiaoyao Powder (XYP) for treating non-alcoholic fatty liver disease (NAFLD), including its impact on serum markers like alanine aminotransferase (ALT).", "results_summary": "XYP, either alone or combined with essential treatment, improved NAFLD by regulating serum markers such as TC, TG, ALT, AST, GGT, and adiponectin. Some adverse events (e.g., flatulence, constipation, diarrhea, rash) were reported in studies involving statins, but others reported no safety concerns.", "population_specificity": "1012 participants with NAFLD across 12 studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:15.811131+00:00"}
{"study_id": 102950, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers were investigating the clinical implications of elevated alanine aminotransferase levels in a pregnant SLE patient with CMV infection, not the safety or efficacy of alanine as a supplement.", "results_summary": "Elevated alanine aminotransferase levels were observed during SLE exacerbation in a pregnant patient with primary CMV infection, leading to severe fetal complications. The study did not assess alanine as a supplement or its effects.", "population_specificity": "A 19-year-old Japanese primigravida with SLE receiving immunosuppressive therapy.", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:16.775177+00:00"}
{"study_id": 102951, "supplement_id": 863, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers investigated the safety, antiviral activity, and pharmacokinetics of JNJ-64530440 (a hepatitis B virus capsid assembly modulator) in patients with chronic hepatitis B.", "results_summary": "JNJ-64530440 demonstrated potent antiviral activity, significantly reducing HBV DNA and RNA levels, and was well tolerated with mild-to-moderate adverse events. The drug's pharmacokinetics in CHB patients were comparable to those in healthy volunteers.", "population_specificity": "Treatment-naive, HBeAg-positive or -negative chronic hepatitis B patients (mean age 43.8 years; 85% male; 70% White).", "effective_dosage": "750 mg once or twice daily.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:21.336748+00:00"}
{"study_id": 102953, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess changes in plasma metabolites, including N-methyl alanine, after HCV clearance with DAAs and their association with liver disease scores in HIV/HCV-coinfected patients with advanced cirrhosis.", "results_summary": "The study found that N-methyl alanine increased after HCV clearance, but its specific effects or associations with liver disease scores were not detailed in the abstract. Other metabolites showed significant associations with improvements in cirrhosis scores and inflammatory status.", "population_specificity": "HIV/HCV-coinfected patients with advanced HCV-related cirrhosis.", "effective_dosage": "Not specified", "study_duration": "36 weeks after sustained virologic response (SVR)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:21.562351+00:00"}
{"study_id": 102955, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the perioperative outcomes of two surgical approaches (dorsal vs. ventral) for laparoscopic left hemihepatectomy, focusing on MHV exposure quality and postoperative complications.", "results_summary": "The dorsal approach showed comparable operative time and blood loss to the ventral approach but had better MHV exposure quality and fewer postoperative complications, including lower increases in liver enzymes (AST and ALT).", "population_specificity": "38 patients undergoing laparoscopic left hemihepatectomy across four university hospitals (2016\u20132021).", "effective_dosage": "Not applicable", "study_duration": "Perioperative period (up to 7 days post-surgery)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:21.790443+00:00"}
{"study_id": 102954, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the long-term safety and efficacy of duodenal mucosal resurfacing (DMR) on metabolic parameters, including alanine aminotransferase (ALT) levels, in patients with type 2 diabetes.", "results_summary": "The study found that ALT levels decreased significantly from baseline to 24 months post-DMR, indicating improved hepatic function. DMR also led to sustained reductions in HbA1c and improvements in cardiovascular markers without serious adverse events.", "population_specificity": "Patients with type 2 diabetes (HbA1c 7.5-10.0%) on oral medication.", "effective_dosage": "Not specified (endoscopic procedure, not a supplement).", "study_duration": "24 months of follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:22.497947+00:00"}
{"study_id": 102952, "supplement_id": 863, "safety_score": "80", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy and safety of recaticimab (a monoclonal antibody against PCSK9) as an add-on therapy for patients with hypercholesterolemia, focusing on LDL-C reduction.", "results_summary": "Recaticimab significantly reduced LDL-C levels by 48.37% to 59.51% compared to placebo, with no serious treatment-emergent adverse events reported. Common mild adverse events included increased alanine aminotransferase, upper respiratory tract infection, and elevated blood glucose.", "population_specificity": "Patients with hypercholesterolemia receiving stable doses of atorvastatin (10 or 20 mg/day) and baseline LDL-C levels \u22652.6 mmol/L.", "effective_dosage": "75 mg every 4 weeks, 150 mg every 4 or 8 weeks, 300 mg every 8 or 12 weeks, and 450 mg every 12 weeks.", "study_duration": "16 weeks for Q4W and Q8W schedules, 24 weeks for Q12W schedules.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:23.322368+00:00"}
{"study_id": 102958, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify causal relationships between gut microbiome features and blood metabolites, including alanine, using Mendelian randomization.", "results_summary": "The study found that alanine, along with other metabolites like glutamate and selenium, influenced members of Proteobacteria in the gut microbiome. No direct health outcomes related to alanine supplementation were reported.", "population_specificity": "3,432 Chinese individuals with whole-genome, whole-metagenome, anthropometric, and blood metabolic trait data.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:23.849277+00:00"}
{"study_id": 102957, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the clinical, histological, and molecular features of never-decompensated alcohol-related liver disease (ndALD) and alcohol-related hepatitis (AH), focusing on liver function and gene expression.", "results_summary": "The study found that AH patients had worse liver function, higher mortality, and more severe histological features (e.g., advanced fibrosis, bilirubinostasis) compared to ndALD patients. Transcriptome analysis revealed distinct gene dysregulation patterns in ndALD (matrisome, immune response) and AH (hepatocyte reprogramming, bile acid metabolism).", "population_specificity": "Patients with never-decompensated ALD (n=110) and alcohol-related hepatitis (n=225).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:24.432745+00:00"}
{"study_id": 102956, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to assess the combination of camrelizumab and apatinib as a second-line treatment for advanced oesophageal squamous cell carcinoma, not specifically focused on Alanine.", "results_summary": "The study found that camrelizumab combined with apatinib showed promising activity and manageable toxicity in patients with advanced oesophageal squamous cell carcinoma, with 34.6% achieving a confirmed objective response. Increased alanine aminotransferase was noted as a common grade 3 or worse treatment-related adverse event in 10% of patients.", "population_specificity": "Patients aged 18-75 years with unresectable locally advanced, locally recurrent, or metastatic oesophageal squamous cell carcinoma who had progressed after or were intolerant to first-line chemotherapy.", "effective_dosage": "Not applicable (study focused on camrelizumab and apatinib, not Alanine).", "study_duration": "Until disease progression, unacceptable adverse events, or withdrawal of consent (median follow-up 7.5 months).", "interactions": "None mentioned (study focused on camrelizumab and apatinib).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:25.842157+00:00"}
{"study_id": 102962, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not address Alanine; it focuses on the efficacy of abiraterone acetate and prednisolone, with or without enzalutamide, in men with high-risk non-metastatic prostate cancer.", "results_summary": "The study does not report any findings related to Alanine.", "population_specificity": "Men with high-risk non-metastatic prostate cancer.", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:28.779449+00:00"}
{"study_id": 102961, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study did not investigate Alanine; it focused on the safety and efficacy of stereotactic ablative body radiotherapy (SABR) and pembrolizumab in oligometastatic clear cell renal cell carcinoma (ccRCC).", "results_summary": "The study did not examine Alanine; it reported outcomes related to SABR and pembrolizumab, including treatment-related adverse events and disease control rates.", "population_specificity": "Patients with oligometastatic clear cell renal cell carcinoma (ccRCC) and one to five oligometastases.", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:29.650307+00:00"}
{"study_id": 102960, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in treating hepatic steatosis and fibrosis in patients with type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD).", "results_summary": "The abstract does not provide specific results regarding Alanine, as the focus was on GLP-1RAs. The study conducted a systematic review and meta-analysis of randomized controlled trials to assess these outcomes.", "population_specificity": "Patients with T2DM and NAFLD.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:29.712989+00:00"}
{"study_id": 102963, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to compare the epidemiological and clinical features of NAFLD and MAFLD, including the role of alanine aminotransferase (ALT) as a marker of liver damage.", "results_summary": "The study found that the MAFLD-only group had significantly higher alanine aminotransferase (ALT) levels (mean difference: 8.0 U/L) compared to the NAFLD-only group, indicating greater liver damage in the MAFLD-defined population.", "population_specificity": "General and non-general populations with fatty liver disease (9,808,677 individuals across 17 studies).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:30.309711+00:00"}
{"study_id": 102964, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the current literature on NAFLD and NASH, including the role of alanine aminotransferase as a diagnostic marker in children and adults.", "results_summary": "The study found that alanine aminotransferase levels are used as a diagnostic marker for NAFLD in children, while adults have additional diagnostic modalities. NAFLD and NASH prevalence varies significantly between children and adults, with NASH posing a higher risk of progressive liver disease.", "population_specificity": "Children and adults with NAFLD or NASH.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:31.442139+00:00"}
{"study_id": 102966, "supplement_id": 863, "safety_score": "85", "efficacy_score": null, "quality_score": 80, "study_goal": "The researchers aimed to assess the hepatic safety of cipargamin (KAE609) across various doses in patients with uncomplicated falciparum malaria, comparing it to artemether-lumefantrine.", "results_summary": "The study found no significant difference in hepatic adverse events between cipargamin and artemether-lumefantrine, with cipargamin being well-tolerated and showing no safety concerns. Previous concerns about hepatic safety may have been influenced by factors like malaria infection itself.", "population_specificity": "Adults with uncomplicated falciparum malaria in five sub-Saharan African countries.", "effective_dosage": "Single doses of 10 to 150 mg and 10 to 50 mg once daily for 3 days.", "study_duration": "4-week trial period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:33.939792+00:00"}
{"study_id": 102965, "supplement_id": 863, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the efficacy and safety of calcineurin inhibitor (CNI) combined with Tripterygium wilfordii polyglycoside tablets (TWPs) versus CNI combined with glucocorticoids (GCs) in treating idiopathic membranous nephropathy (IMN), including monitoring alanine aminotransferase levels.", "results_summary": "Both treatment groups showed significant reductions in 24-hour urine protein levels and improvements in serum albumin and lipid profiles. The TWP group demonstrated faster reduction in proteinuria at 6 months, but no significant differences in overall outcomes or side effects were observed between the groups.", "population_specificity": "Patients with idiopathic membranous nephropathy (IMN) treated at the Affiliated Hospital of Shandong University of Traditional Chinese Medicine.", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:34.368236+00:00"}
{"study_id": 102967, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the hepatitis B surface antigen (HBsAg) reduction potential of switching from entecavir (ETV) to tenofovir disoproxil fumarate (TDF) in HBeAg-positive chronic hepatitis B patients with undetectable serum HBV-DNA.", "results_summary": "At week 48, only 4% of participants achieved a 0.25 log reduction in HBsAg, indicating limited HBsAg reduction after switching from ETV to TDF. The study concluded that further investigation is needed to understand the clinical impact of this switch.", "population_specificity": "HBeAg-positive chronic hepatitis B patients with undetectable serum HBV-DNA.", "effective_dosage": "TDF 300 mg once daily.", "study_duration": "96 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:35.095492+00:00"}
{"study_id": 102970, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of camrelizumab plus TACE versus TACE alone in treating massive hepatocellular carcinoma (HCC) patients.", "results_summary": "The study found that camrelizumab plus TACE improved liver function and treatment outcomes compared to TACE alone, with fewer required TACE sessions in the study group.", "population_specificity": "Patients with massive hepatocellular carcinoma (HCC).", "effective_dosage": "Not specified for Alanine.", "study_duration": "Patients were followed for 7 to 24 months (median 12 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:37.182834+00:00"}
{"study_id": 102969, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The study aimed to evaluate the effectiveness of TACE combined with a targeted nanoparticle delivery system for sorafenib in treating hepatocellular carcinoma with microvascular invasion, not Alanine.", "results_summary": "The study compared TACE combined with a targeted nanoparticle delivery system for sorafenib versus TACE with a non-nano drug delivery system in HCC patients with microvascular invasion. No significant differences in liver function or blood test results were observed between the groups before and one month after treatment.", "population_specificity": "42 HCC patients with microvascular invasion post-liver cancer surgery.", "effective_dosage": "Not specified for Alanine.", "study_duration": "Intervention duration not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:37.350340+00:00"}
{"study_id": 102971, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to identify high-risk factors and develop a predictive model (BNR-6) for biochemical nonresolution (BNR) in patients with chronic drug-induced liver injury (DILI), focusing on alanine aminotransferase and other liver enzymes.", "results_summary": "The study found that significant liver inflammation and fibrosis stages were strongly associated with BNR, with a 21.3-fold increased risk in patients with significant inflammation. The BNR-6 model, incorporating biochemical and demographic factors, showed high predictive accuracy (concordance index 0.824).", "population_specificity": "Patients with chronic DILI (n=3655, with 2866 undergoing liver biopsy) from nine hospitals.", "effective_dosage": "Not specified", "study_duration": "Follow-up over 1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:38.820962+00:00"}
{"study_id": 102972, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of a tailored probiotic and micronutrient mixture on serum alanine aminotransferase (ALAT) levels in obese patients after mini gastric bypass surgery.", "results_summary": "The study found no significant difference in ALAT changes between groups, but the tailored probiotic and micronutrient mixture improved other NAFLD-related markers, including serum ASAT, NAFLD fibrosis score, triglycerides, and visceral adiposity index.", "population_specificity": "60 obese patients (age: 40 \u00b1 10 y; BMI: 44 \u00b1 3 kg/m\u00b2) undergoing mini gastric bypass surgery.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:38.947981+00:00"}
{"study_id": 102975, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to identify biomarkers of appetite response using a dose-rising whey protein preload intervention, not specifically focused on Alanine.", "results_summary": "The abstract does not provide specific findings related to Alanine's effects.", "population_specificity": "Female participants (n=24) with BMI between 23 and 40 kg/m\u00b2.", "effective_dosage": "Not specified for Alanine.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:40.715160+00:00"}
{"study_id": 102974, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers compared the antitumor efficacy and adverse effects of crizotinib and alectinib in ALK-positive non-small cell lung cancer (NSCLC) patients.", "results_summary": "Alectinib showed superior efficacy in progression-free survival, overall survival, CNS progression-free survival, and response rates compared to crizotinib, with fewer severe adverse effects. The crizotinib group reported higher rates of gastrointestinal and hepatic adverse effects, including elevated alanine aminotransferase levels.", "population_specificity": "ALK-positive non-small cell lung cancer (NSCLC) patients.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:41.147029+00:00"}
{"study_id": 102976, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers examined the effects of dietary sugar restriction on hepatic de novo lipogenesis (DNL) and its correlation with metabolic outcomes, including alanine aminotransferase (ALT) levels, in adolescents with NAFLD.", "results_summary": "The study found that dietary sugar restriction significantly reduced hepatic DNL and fasting insulin, with a notable correlation between changes in DNL and ALT levels (r = 0.39, P = 0.049), suggesting a metabolic link. However, no direct causal relationship between alanine and outcomes was established.", "population_specificity": "Adolescent boys with nonalcoholic fatty liver disease (NAFLD) (n = 29).", "effective_dosage": "Not specified (intervention was a diet low in free sugars).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:44.029085+00:00"}
{"study_id": 102977, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to determine the optimal dose of ponatinib combined with FLAG-IDA for treating blast-phase chronic myeloid leukaemia, not specifically to evaluate alanine.", "results_summary": "The study found that ponatinib-FLAG-IDA induced a second chronic phase in 69% of patients, with some experiencing dose-limiting toxicities, including grade 4 increased alanine aminotransferase.", "population_specificity": "Adults (aged \u226516 years) with Philadelphia chromosome-positive or BCR-ABL1-positive blast-phase chronic myeloid leukaemia.", "effective_dosage": "Not applicable (alanine was not the focus of the study).", "study_duration": "Up to two cycles of treatment (each cycle duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:44.153637+00:00"}
{"study_id": 102978, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent advances in novel clinical biomarkers for drug-induced liver injury (DILI) and evaluate their potential to complement traditional biomarkers like alanine aminotransferase (ALT).", "results_summary": "The abstract highlights that traditional biomarkers like ALT lack specificity and sensitivity for DILI, and while novel biomarkers show promise, most still lack comprehensive validation for clinical use.", "population_specificity": "Not specified (general discussion of clinical biomarkers for DILI).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:44.823891+00:00"}
{"study_id": 102979, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of tenofovir alafenamide (TAF) in pregnant women with active chronic hepatitis B (CHB) and their infants.", "results_summary": "The study found that TAF was generally safe and effective for pregnant women with active CHB and their infants, with no significant adverse events reported in the TAF group. Infants in both TAF and TDF groups received immunoprophylaxis and showed no defects or significant safety concerns.", "population_specificity": "Pregnant women with active chronic hepatitis B (immune clearance and reactivation phases) and their infants.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Throughout or beginning in early pregnancy (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:46.286843+00:00"}
{"study_id": 102981, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to identify risk factors, including raised alanine transaminase levels, associated with hepatocellular carcinoma (HCC) in type 2 diabetes mellitus (T2DM) patients.", "results_summary": "The study found that raised alanine transaminase levels were a significant risk factor for HCC in T2DM patients (AOR = 2.11, 95% CI: 1.16-3.86). Statins reduced HCC risk, but no direct efficacy of alanine itself was evaluated.", "population_specificity": "T2DM patients from two hepatobiliary referral centers in a developing country (212 case-control pairs).", "effective_dosage": "Not specified", "study_duration": "Data extracted from medical records between 1 January 2012 and 30 June 2018 (retrospective analysis).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:48.162064+00:00"}
{"study_id": 102980, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to investigate the effects of valproate (VPA) treatment on gut microbiota and its association with metabolic parameters, including alanine aminotransferase, in patients with epilepsy.", "results_summary": "VPA treatment altered the gut microbiota composition, particularly increasing the Firmicutes to Bacteriodetes ratio, and correlated with metabolic parameters like alanine aminotransferase, suggesting a potential role in VPA-induced metabolic disorders.", "population_specificity": "10 newly diagnosed, treatment-na\u00efve patients with cryptogenic epilepsy.", "effective_dosage": "1000 mg daily doses of VPA.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:48.527884+00:00"}
{"study_id": 102983, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether microecological agents, including potential components like Alanine, could improve immune function and alleviate endotoxemia and hyperbilirubinemia in patients undergoing hepatectomy for hepatocellular carcinoma.", "results_summary": "Microecological agents significantly reduced total bilirubin levels and postoperative infection risk but did not show significant effects on ALT, AST, prothrombin, or CRP levels. The study confirmed their benefits for immune function and certain metabolic markers.", "population_specificity": "Patients with hepatocellular carcinoma undergoing hepatectomy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:49.138540+00:00"}
{"study_id": 102982, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy of probiotics, including their impact on alanine aminotransferase (ALT) levels, in improving liver function and reducing blood lipid levels in patients with NAFLD.", "results_summary": "Probiotic therapy significantly reduced serum ALT, AST, and total cholesterol levels in NAFLD patients compared to the control group, though it did not affect BMI, HOMA-IR, or TNF. Subgroup analyses suggested that specific probiotic combinations or longer treatment durations could reduce BMI.", "population_specificity": "352 patients with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Varied, with some treatments lasting more than three months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:49.723286+00:00"}
{"study_id": 102984, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and toxicity of combined neonatal prophylaxis (CNP) in infants at high-risk of HIV-1 perinatal transmission, not specifically focusing on Alanine.", "results_summary": "The study found no differences in increased alanine aminotransferase levels between infants receiving CNP and those on monotherapy, suggesting no significant adverse effects related to Alanine. However, the primary focus was on overall safety and transmission rates, not Alanine-specific outcomes.", "population_specificity": "Newborns at high-risk of HIV-1 perinatal transmission and their mothers in the Madrid Cohort.", "effective_dosage": "Not specified for Alanine.", "study_duration": "Not specified for Alanine.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:52.665313+00:00"}
{"study_id": 102985, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effectiveness of entecavir co-administered with DAA in preventing HBV virologic and clinical reactivation in HCV/HBV dually infected patients.", "results_summary": "The study found that co-administration of entecavir with DAA significantly reduced HBV reactivation during treatment (0% in groups 2 and 3 vs. 50% in group 1), though reactivation occurred after entecavir cessation. Clinical reactivation was rare (5.4%).", "population_specificity": "Noncirrhotic patients with dual HCV/HBV infection.", "effective_dosage": "12 weeks of DAA plus 12 or 24 weeks of entecavir.", "study_duration": "72 weeks (total study duration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:52.979662+00:00"}
